| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MAP9 MYH11 ANK2 ANK3 OFD1 CETN3 SYNE1 SPTAN1 FMNL2 MYLK2 MYO5C SMC3 CEP44 SYNE2 DIAPH1 DIAPH2 MACF1 CEP295 CTNNA1 KIF5B DMD TNNC1 CAMSAP1 UTRN | 3.31e-06 | 1099 | 153 | 24 | GO:0008092 |
| GeneOntologyMolecularFunction | calcium ion binding | PRRG1 TBC1D9B VSNL1 MYL1 CALB2 SWAP70 CETN3 SPTAN1 PON1 NCL MICU3 MYL6B EHD1 ITSN2 MACF1 TNNC1 PCDH1 | 6.33e-05 | 749 | 153 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | actin binding | MYH11 SYNE1 SPTAN1 FMNL2 MYO5C SYNE2 DIAPH1 DIAPH2 MACF1 CTNNA1 DMD TNNC1 UTRN | 8.40e-05 | 479 | 153 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | vinculin binding | 1.19e-04 | 13 | 153 | 3 | GO:0017166 | |
| GeneOntologyMolecularFunction | spectrin binding | 1.29e-04 | 34 | 153 | 4 | GO:0030507 | |
| GeneOntologyMolecularFunction | cadherin binding | UBAP2 ANK3 SWAP70 SPTAN1 TRPC4 FMNL2 EHD1 MACF1 CTNNA1 KIF5B | 2.93e-04 | 339 | 153 | 10 | GO:0045296 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.98e-04 | 118 | 153 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 3.24e-04 | 43 | 153 | 4 | GO:0008307 | |
| GeneOntologyMolecularFunction | myosin light chain kinase activity | 3.46e-04 | 4 | 153 | 2 | GO:0004687 | |
| GeneOntologyMolecularFunction | actin filament binding | 3.72e-04 | 227 | 153 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 5.75e-04 | 5 | 153 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | UBAP2 ANK3 SWAP70 EMB SPTAN1 TRPC4 FMNL2 EHD1 MACF1 CTNNA1 KIF5B DMD UTRN | 7.24e-04 | 599 | 153 | 13 | GO:0050839 |
| GeneOntologyMolecularFunction | arylesterase activity | 8.57e-04 | 6 | 153 | 2 | GO:0004064 | |
| GeneOntologyMolecularFunction | dynein complex binding | 1.26e-03 | 28 | 153 | 3 | GO:0070840 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 1.72e-03 | 112 | 153 | 5 | GO:0090079 | |
| GeneOntologyBiologicalProcess | organelle assembly | CFAP47 TRAF7 MAP9 CLUAP1 MYH11 TBC1D9B MNS1 OFD1 RSPH4A CEP162 SYNE1 CNTRL CCDC38 ODF2L SMC3 UBAP2L CEP44 SYNE2 EHD1 EIF5B CC2D2A GPSM2 CEP295 BIN2 MPHOSPH9 PRKDC STX17 WNK3 CCDC63 | 2.45e-09 | 1138 | 149 | 29 | GO:0070925 |
| GeneOntologyBiologicalProcess | cilium assembly | CFAP47 CLUAP1 TBC1D9B MNS1 OFD1 RSPH4A CEP162 SYNE1 CNTRL CCDC38 ODF2L SYNE2 EHD1 CC2D2A MPHOSPH9 CCDC63 | 1.45e-07 | 444 | 149 | 16 | GO:0060271 |
| GeneOntologyBiologicalProcess | microtubule-based process | CFAP47 MAP9 CLUAP1 ANK3 MNS1 OFD1 RSPH4A SEPTIN4 CETN3 CNTRL CCDC38 SMC3 ATXN7 CEP44 SYNE2 DIAPH1 CC2D2A GPSM2 MACF1 CEP295 KIF5B CAMSAP1 DNAH9 ARHGAP21 CCDC63 | 1.56e-07 | 1058 | 149 | 25 | GO:0007017 |
| GeneOntologyBiologicalProcess | cilium organization | CFAP47 CLUAP1 TBC1D9B MNS1 OFD1 RSPH4A CEP162 SYNE1 CNTRL CCDC38 ODF2L SYNE2 EHD1 CC2D2A MPHOSPH9 CCDC63 | 3.69e-07 | 476 | 149 | 16 | GO:0044782 |
| GeneOntologyBiologicalProcess | axoneme assembly | 1.26e-06 | 109 | 149 | 8 | GO:0035082 | |
| GeneOntologyBiologicalProcess | muscle filament sliding | 3.36e-06 | 15 | 149 | 4 | GO:0030049 | |
| GeneOntologyBiologicalProcess | positive regulation of sodium ion transmembrane transporter activity | 4.45e-06 | 16 | 149 | 4 | GO:2000651 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CFAP47 MAP9 CLUAP1 ANK3 MNS1 OFD1 RSPH4A CETN3 CNTRL SMC3 ATXN7 CEP44 SYNE2 CC2D2A GPSM2 CEP295 CAMSAP1 CCDC63 | 4.68e-06 | 720 | 149 | 18 | GO:0000226 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | CFAP47 CLUAP1 TBC1D9B MNS1 OFD1 RSPH4A CEP162 SYNE1 CNTRL CCDC38 ODF2L SYNE2 EHD1 CC2D2A MPHOSPH9 PLD1 CCDC63 | 7.23e-06 | 670 | 149 | 17 | GO:0120031 |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 7.40e-06 | 18 | 149 | 4 | GO:0033275 | |
| GeneOntologyBiologicalProcess | cell projection assembly | CFAP47 CLUAP1 TBC1D9B MNS1 OFD1 RSPH4A CEP162 SYNE1 CNTRL CCDC38 ODF2L SYNE2 EHD1 CC2D2A MPHOSPH9 PLD1 CCDC63 | 9.65e-06 | 685 | 149 | 17 | GO:0030031 |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 1.06e-05 | 145 | 149 | 8 | GO:0001578 | |
| GeneOntologyBiologicalProcess | multicellular organismal movement | 1.47e-05 | 73 | 149 | 6 | GO:0050879 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.57e-05 | 153 | 149 | 8 | GO:0030048 | |
| GeneOntologyBiologicalProcess | positive regulation of sodium ion transmembrane transport | 1.73e-05 | 22 | 149 | 4 | GO:1902307 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | TRAF7 MAP9 MYH11 OFD1 SMC3 UBAP2L CEP44 EIF5B GPSM2 CEP295 BIN2 PRKDC WNK3 | 4.24e-05 | 475 | 149 | 13 | GO:0140694 |
| GeneOntologyBiologicalProcess | regulation of sodium ion transmembrane transporter activity | 5.69e-05 | 57 | 149 | 5 | GO:2000649 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | CFAP47 CLUAP1 ANK3 MNS1 OFD1 RSPH4A SEPTIN4 CCDC38 SYNE2 KIF5B DNAH9 ARHGAP21 CCDC63 | 6.19e-05 | 493 | 149 | 13 | GO:0007018 |
| GeneOntologyBiologicalProcess | microtubule-based transport | 9.57e-05 | 253 | 149 | 9 | GO:0099111 | |
| GeneOntologyBiologicalProcess | centrosome localization | 1.15e-04 | 35 | 149 | 4 | GO:0051642 | |
| GeneOntologyBiologicalProcess | spermatid development | 1.25e-04 | 262 | 149 | 9 | GO:0007286 | |
| GeneOntologyBiologicalProcess | positive regulation of transporter activity | 1.27e-04 | 107 | 149 | 6 | GO:0032411 | |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 1.29e-04 | 36 | 149 | 4 | GO:0061842 | |
| GeneOntologyBiologicalProcess | regulation of cilium assembly | 1.34e-04 | 108 | 149 | 6 | GO:1902017 | |
| GeneOntologyBiologicalProcess | regulation of sodium ion transmembrane transport | 1.42e-04 | 69 | 149 | 5 | GO:1902305 | |
| GeneOntologyBiologicalProcess | spermatid differentiation | 1.65e-04 | 272 | 149 | 9 | GO:0048515 | |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | 2.05e-04 | 280 | 149 | 9 | GO:1902115 | |
| GeneOntologyBiologicalProcess | positive regulation of sodium ion transport | 2.36e-04 | 42 | 149 | 4 | GO:0010765 | |
| GeneOntologyBiologicalProcess | neuron projection retraction | 3.08e-04 | 4 | 149 | 2 | GO:0106028 | |
| GeneOntologyBiologicalProcess | multicellular organismal locomotion | 3.08e-04 | 4 | 149 | 2 | GO:0071965 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 3.24e-04 | 127 | 149 | 6 | GO:0070252 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | TBC1D9B MNS1 SWAP70 SYNE1 SPTAN1 UBE3B VPS8 ADGRB3 ODF2L GBP5 UBAP2L SYNE2 GPC4 FNIP1 GPSM2 MACF1 CEP295 MPHOSPH9 PLD1 CAMSAP1 | 3.63e-04 | 1189 | 149 | 20 | GO:0044087 |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle contraction | 3.85e-04 | 20 | 149 | 3 | GO:0014819 | |
| GeneOntologyBiologicalProcess | regulation of muscle filament sliding | 5.11e-04 | 5 | 149 | 2 | GO:0032971 | |
| GeneOntologyBiologicalProcess | skeletal muscle contraction | 5.41e-04 | 52 | 149 | 4 | GO:0003009 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | CFAP47 KLHL10 MNS1 SEPTIN4 SYNE1 CNTRL TEX15 PPARD CNBD2 CCDC38 LARP7 EIF2S2 PRKACG DIAPH2 CTNNA1 PRKDC EIF4G3 AFF4 CCDC63 PMFBP1 | 5.87e-04 | 1235 | 149 | 20 | GO:0003006 |
| GeneOntologyBiologicalProcess | positive regulation of potassium ion transport | 6.25e-04 | 54 | 149 | 4 | GO:0043268 | |
| GeneOntologyBiologicalProcess | cilium movement | 6.34e-04 | 261 | 149 | 8 | GO:0003341 | |
| GeneOntologyBiologicalProcess | muscle contraction | 6.73e-04 | 400 | 149 | 10 | GO:0006936 | |
| GeneOntologyBiologicalProcess | positive regulation of ion transmembrane transporter activity | 6.95e-04 | 97 | 149 | 5 | GO:0032414 | |
| GeneOntologyBiologicalProcess | gamete generation | CFAP47 KLHL10 MNS1 SEPTIN4 SYNE1 CNTRL TEX15 CNBD2 CCDC38 LARP7 EIF2S2 PRKACG DIAPH2 EIF4G3 AFF4 CCDC63 PMFBP1 | 7.49e-04 | 982 | 149 | 17 | GO:0007276 |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH11 MYL1 ANK2 ANK3 SYNE1 SPTAN1 MYLK2 MYL6B SYNE2 DMD TNNC1 | 8.19e-06 | 290 | 150 | 11 | GO:0043292 |
| GeneOntologyCellularComponent | cilium | CFAP47 CLUAP1 MNS1 OFD1 RSPH4A SEPTIN4 CETN3 CEP162 CNTRL TOMM20 CCDC38 ODF2L EHD1 PRKACG CC2D2A KIF5B DNAH9 CCDC63 PMFBP1 | 2.41e-05 | 898 | 150 | 19 | GO:0005929 |
| GeneOntologyCellularComponent | supramolecular fiber | MAP9 KRT7 MYH11 MYL1 ANK2 ANK3 MNS1 CEP162 SYNE1 SPTAN1 MYLK2 MYL6B SYNE2 DIAPH1 DIAPH2 MACF1 CEP295 KIF5B DMD TNNC1 CAMSAP1 DNAH9 | 3.61e-05 | 1179 | 150 | 22 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MAP9 KRT7 MYH11 MYL1 ANK2 ANK3 MNS1 CEP162 SYNE1 SPTAN1 MYLK2 MYL6B SYNE2 DIAPH1 DIAPH2 MACF1 CEP295 KIF5B DMD TNNC1 CAMSAP1 DNAH9 | 3.99e-05 | 1187 | 150 | 22 | GO:0099081 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH11 MYL1 CALB2 SWAP70 SPTAN1 MYO5C MYL6B DIAPH1 DIAPH2 MACF1 BIN2 CTNNA1 TNNC1 ARHGAP21 | 7.17e-05 | 576 | 150 | 14 | GO:0015629 |
| GeneOntologyCellularComponent | sarcomere | 8.07e-05 | 249 | 150 | 9 | GO:0030017 | |
| GeneOntologyCellularComponent | myofibril | 1.62e-04 | 273 | 150 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | muscle myosin complex | 1.89e-04 | 16 | 150 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | centriole | 2.48e-04 | 172 | 150 | 7 | GO:0005814 | |
| GeneOntologyCellularComponent | filopodium membrane | 4.38e-04 | 21 | 150 | 3 | GO:0031527 | |
| GeneOntologyCellularComponent | centrosome | CLUAP1 OFD1 CETN3 CEP162 CNTRL CCDC38 ODF2L NFE2L2 CEP44 ITSN2 DIAPH1 GPSM2 CEP295 MPHOSPH9 KIF5B | 4.39e-04 | 770 | 150 | 15 | GO:0005813 |
| GeneOntologyCellularComponent | costamere | 5.05e-04 | 22 | 150 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | mitochondria-associated endoplasmic reticulum membrane contact site | 5.77e-04 | 23 | 150 | 3 | GO:0044233 | |
| GeneOntologyCellularComponent | myosin complex | 8.53e-04 | 59 | 150 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | microtubule organizing center | CLUAP1 OFD1 CETN3 CEP162 CNTRL CCDC38 ODF2L NFE2L2 CEP44 ITSN2 DIAPH1 GPSM2 CEP295 MPHOSPH9 KIF5B CAMSAP1 | 9.48e-04 | 919 | 150 | 16 | GO:0005815 |
| GeneOntologyCellularComponent | myosin II complex | 1.04e-03 | 28 | 150 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | motile cilium | 1.08e-03 | 355 | 150 | 9 | GO:0031514 | |
| GeneOntologyCellularComponent | intercalated disc | 1.45e-03 | 68 | 150 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 1.68e-03 | 238 | 150 | 7 | GO:0097729 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 1.78e-03 | 9 | 150 | 2 | GO:0031095 | |
| GeneOntologyCellularComponent | spindle | MAP9 CEP162 CNTRL DIDO1 CHAMP1 SMC3 CEP44 DIAPH1 GPSM2 CEP295 | 2.17e-03 | 471 | 150 | 10 | GO:0005819 |
| GeneOntologyCellularComponent | centriolar satellite | 2.32e-03 | 128 | 150 | 5 | GO:0034451 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 2.70e-03 | 11 | 150 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 2.70e-03 | 11 | 150 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 2.70e-03 | 11 | 150 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 2.70e-03 | 11 | 150 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | paranodal junction | 2.70e-03 | 11 | 150 | 2 | GO:0033010 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 2.70e-03 | 11 | 150 | 2 | GO:0031094 | |
| Domain | EF-hand-dom_pair | TBC1D9B VSNL1 MYL1 CALB2 SWAP70 CETN3 SPTAN1 LRRC74A MICU3 MYL6B EHD1 ITSN2 MACF1 DMD TNNC1 UTRN | 7.51e-10 | 287 | 144 | 16 | IPR011992 |
| Domain | - | TBC1D9B VSNL1 MYL1 CALB2 CETN3 SPTAN1 LRRC74A MICU3 MYL6B EHD1 ITSN2 MACF1 DMD TNNC1 UTRN | 1.73e-09 | 261 | 144 | 15 | 1.10.238.10 |
| Domain | Spectrin | 1.71e-08 | 23 | 144 | 6 | PF00435 | |
| Domain | EF-hand_1 | VSNL1 MYL1 CALB2 CETN3 SPTAN1 MICU3 MYL6B EHD1 ITSN2 MACF1 TNNC1 | 2.67e-08 | 152 | 144 | 11 | PF00036 |
| Domain | EF_hand_dom | TBC1D9B VSNL1 MYL1 CALB2 SWAP70 CETN3 SPTAN1 MICU3 MYL6B EHD1 ITSN2 MACF1 TNNC1 | 3.00e-08 | 232 | 144 | 13 | IPR002048 |
| Domain | Spectrin_repeat | 7.77e-08 | 29 | 144 | 6 | IPR002017 | |
| Domain | SPEC | 1.45e-07 | 32 | 144 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.45e-07 | 32 | 144 | 6 | IPR018159 | |
| Domain | EF_HAND_2 | TBC1D9B VSNL1 MYL1 CALB2 CETN3 SPTAN1 MICU3 MYL6B EHD1 ITSN2 MACF1 TNNC1 | 2.37e-07 | 231 | 144 | 12 | PS50222 |
| Domain | EFh | 4.10e-07 | 158 | 144 | 10 | SM00054 | |
| Domain | ACTININ_2 | 7.65e-07 | 23 | 144 | 5 | PS00020 | |
| Domain | ACTININ_1 | 7.65e-07 | 23 | 144 | 5 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 7.65e-07 | 23 | 144 | 5 | IPR001589 | |
| Domain | CH | 1.49e-06 | 73 | 144 | 7 | PS50021 | |
| Domain | CH-domain | 1.79e-06 | 75 | 144 | 7 | IPR001715 | |
| Domain | EF_Hand_1_Ca_BS | 8.72e-06 | 175 | 144 | 9 | IPR018247 | |
| Domain | CH | 1.65e-05 | 70 | 144 | 6 | PF00307 | |
| Domain | - | 1.79e-05 | 71 | 144 | 6 | 1.10.418.10 | |
| Domain | DAD_dom | 2.44e-05 | 8 | 144 | 3 | IPR014767 | |
| Domain | DAD | 2.44e-05 | 8 | 144 | 3 | PS51231 | |
| Domain | EF_HAND_1 | 2.96e-05 | 204 | 144 | 9 | PS00018 | |
| Domain | Drf_GBD | 3.64e-05 | 9 | 144 | 3 | PF06371 | |
| Domain | Drf_FH3 | 3.64e-05 | 9 | 144 | 3 | PF06367 | |
| Domain | FH3_dom | 3.64e-05 | 9 | 144 | 3 | IPR010472 | |
| Domain | GTPase-bd | 3.64e-05 | 9 | 144 | 3 | IPR010473 | |
| Domain | Drf_FH3 | 3.64e-05 | 9 | 144 | 3 | SM01139 | |
| Domain | Drf_GBD | 3.64e-05 | 9 | 144 | 3 | SM01140 | |
| Domain | EF-hand_7 | 5.02e-05 | 85 | 144 | 6 | PF13499 | |
| Domain | Dystrophin | 5.90e-05 | 2 | 144 | 2 | IPR016344 | |
| Domain | DUF3697_Uba2 | 5.90e-05 | 2 | 144 | 2 | IPR022166 | |
| Domain | DUF3697 | 5.90e-05 | 2 | 144 | 2 | PF12478 | |
| Domain | GBD/FH3_dom | 7.08e-05 | 11 | 144 | 3 | IPR014768 | |
| Domain | GBD_FH3 | 7.08e-05 | 11 | 144 | 3 | PS51232 | |
| Domain | CH | 1.45e-04 | 65 | 144 | 5 | SM00033 | |
| Domain | Drf_DAD | 1.76e-04 | 3 | 144 | 2 | PF06345 | |
| Domain | Drf_DAD | 1.76e-04 | 3 | 144 | 2 | IPR010465 | |
| Domain | FH2 | 1.91e-04 | 15 | 144 | 3 | PS51444 | |
| Domain | FH2_Formin | 1.91e-04 | 15 | 144 | 3 | IPR015425 | |
| Domain | FH2 | 1.91e-04 | 15 | 144 | 3 | PF02181 | |
| Domain | FH2 | 1.91e-04 | 15 | 144 | 3 | SM00498 | |
| Domain | KASH | 3.51e-04 | 4 | 144 | 2 | IPR012315 | |
| Domain | KASH | 3.51e-04 | 4 | 144 | 2 | PS51049 | |
| Domain | KASH | 3.51e-04 | 4 | 144 | 2 | SM01249 | |
| Domain | KASH | 3.51e-04 | 4 | 144 | 2 | PF10541 | |
| Domain | Myosin_S1_N | 5.81e-04 | 5 | 144 | 2 | IPR008989 | |
| Domain | HSR | 5.81e-04 | 5 | 144 | 2 | PS51414 | |
| Domain | HSR | 5.81e-04 | 5 | 144 | 2 | PF03172 | |
| Domain | HSR_dom | 5.81e-04 | 5 | 144 | 2 | IPR004865 | |
| Domain | OSR1_C | 8.68e-04 | 6 | 144 | 2 | PF12202 | |
| Domain | Kinase_OSR1/WNK_CCT | 8.68e-04 | 6 | 144 | 2 | IPR024678 | |
| Domain | EF-hand_dom_typ1 | 8.68e-04 | 6 | 144 | 2 | IPR015153 | |
| Domain | EF-hand_dom_typ2 | 8.68e-04 | 6 | 144 | 2 | IPR015154 | |
| Domain | EF-hand_2 | 8.68e-04 | 6 | 144 | 2 | PF09068 | |
| Domain | EF-hand_3 | 8.68e-04 | 6 | 144 | 2 | PF09069 | |
| Domain | Zinc_finger_PHD-type_CS | 1.59e-03 | 65 | 144 | 4 | IPR019786 | |
| Domain | SAND_dom | 1.60e-03 | 8 | 144 | 2 | IPR000770 | |
| Domain | SAND | 1.60e-03 | 8 | 144 | 2 | PF01342 | |
| Domain | SAND | 1.60e-03 | 8 | 144 | 2 | PS50864 | |
| Domain | SAND | 1.60e-03 | 8 | 144 | 2 | SM00258 | |
| Domain | ZU5 | 2.05e-03 | 9 | 144 | 2 | SM00218 | |
| Domain | IQ | 2.21e-03 | 71 | 144 | 4 | PF00612 | |
| Domain | Prefoldin | 2.32e-03 | 72 | 144 | 4 | IPR009053 | |
| Domain | ZU5 | 2.55e-03 | 10 | 144 | 2 | PS51145 | |
| Domain | EF-hand_4 | 2.55e-03 | 10 | 144 | 2 | PF12763 | |
| Domain | PHD | 2.70e-03 | 75 | 144 | 4 | PF00628 | |
| Domain | EH | 3.10e-03 | 11 | 144 | 2 | PS50031 | |
| Domain | EH | 3.10e-03 | 11 | 144 | 2 | SM00027 | |
| Domain | EH_dom | 3.10e-03 | 11 | 144 | 2 | IPR000261 | |
| Domain | Bromodomain | 3.11e-03 | 38 | 144 | 3 | PF00439 | |
| Domain | Znf_PHD-finger | 3.25e-03 | 79 | 144 | 4 | IPR019787 | |
| Domain | IQ | 3.56e-03 | 81 | 144 | 4 | SM00015 | |
| Domain | - | 3.70e-03 | 12 | 144 | 2 | 3.10.390.10 | |
| Domain | ZU5 | 3.70e-03 | 12 | 144 | 2 | PF00791 | |
| Domain | ZU5_dom | 3.70e-03 | 12 | 144 | 2 | IPR000906 | |
| Domain | SAND_dom-like | 3.70e-03 | 12 | 144 | 2 | IPR010919 | |
| Domain | BROMODOMAIN_2 | 3.86e-03 | 41 | 144 | 3 | PS50014 | |
| Domain | Bromodomain | 4.14e-03 | 42 | 144 | 3 | IPR001487 | |
| Domain | BROMO | 4.14e-03 | 42 | 144 | 3 | SM00297 | |
| Domain | - | 4.14e-03 | 42 | 144 | 3 | 1.20.920.10 | |
| Domain | EF-hand_6 | 4.36e-03 | 13 | 144 | 2 | PF13405 | |
| Domain | ARM-type_fold | 4.83e-03 | 339 | 144 | 8 | IPR016024 | |
| Domain | PHD | 4.99e-03 | 89 | 144 | 4 | SM00249 | |
| Domain | IQ_motif_EF-hand-BS | 5.19e-03 | 90 | 144 | 4 | IPR000048 | |
| Domain | Znf_PHD | 5.39e-03 | 91 | 144 | 4 | IPR001965 | |
| Domain | Spectrin_alpha_SH3 | 5.80e-03 | 15 | 144 | 2 | IPR013315 | |
| Domain | Myosin_N | 5.80e-03 | 15 | 144 | 2 | PF02736 | |
| Domain | Myosin_N | 5.80e-03 | 15 | 144 | 2 | IPR004009 | |
| Domain | IQ | 5.82e-03 | 93 | 144 | 4 | PS50096 | |
| Domain | ZF_PHD_2 | 6.27e-03 | 95 | 144 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 6.51e-03 | 96 | 144 | 4 | PS01359 | |
| Domain | BRLZ | 7.53e-03 | 52 | 144 | 3 | SM00338 | |
| Pubmed | MYH11 ANK3 SYNE1 SPTAN1 CNTRL NCL FMNL2 SMC3 ITSN2 DIAPH2 MACF1 MPHOSPH9 CTNNA1 KIF5B PRKDC TAF1 DMD WNK2 GOLGB1 | 6.77e-13 | 486 | 154 | 19 | 20936779 | |
| Pubmed | UBAP2 ANK2 ANK3 SYNE1 SPTAN1 TRPC4 ADGRB3 DIDO1 NCL UBAP2L SYNE2 DIAPH1 DIAPH2 ANKRD28 MACF1 CTNNA1 KIF5B CPSF2 CAMSAP1 ARHGAP21 WNK3 WNK2 GOLGB1 AFF4 | 7.91e-12 | 963 | 154 | 24 | 28671696 | |
| Pubmed | DOCK3 VSNL1 ABCF1 ATP6V0A1 ANK2 ANK3 SYNE1 SPTAN1 ZBTB43 ADGRB3 FMNL2 ODF2L ACAD8 NFE2L2 BTG3 GPSM2 MACF1 CTNNA1 PRKDC TAF1 PALS2 R3HDM1 EIF4G3 UTRN ARHGAP21 AFF4 ZMYM5 | 1.69e-11 | 1285 | 154 | 27 | 35914814 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ABCF1 UBAP2 ANK2 RSF1 DIDO1 NCL PPA1 CHAMP1 UBAP2L CEP44 NAF1 EIF5B ANKRD28 MACF1 RPRD2 KIF5B PRKDC EIF4G3 CAMSAP1 UTRN ARHGAP21 GOLGB1 AFF4 | 2.86e-11 | 934 | 154 | 23 | 33916271 |
| Pubmed | MAP9 KRT7 MYH11 ANK2 SYNE1 SPTAN1 CNTRL RSF1 TOMM20 NCL LARP7 MYLK2 ACSL3 ATXN7 SYNE2 SCN4A ITSN2 GPC4 EIF5B CC2D2A MACF1 CEP295 KIF5B PRKDC DMD EIF4G3 ARHGAP21 GOLGB1 | 4.22e-11 | 1442 | 154 | 28 | 35575683 | |
| Pubmed | ABCF1 SPTAN1 RSF1 KRI1 DIDO1 NCL LARP7 ACSL3 NIFK UBAP2L SYNE2 EIF5B ANKRD28 MACF1 CTNNA1 KIF5B PRKDC EIF4G3 UTRN | 1.09e-10 | 653 | 154 | 19 | 22586326 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | KRT7 ABCF1 UBAP2 SWAP70 SPTAN1 KRI1 DIDO1 UBAP2L EIF5B KIF5B PRKDC GOLGB1 | 1.86e-09 | 256 | 154 | 12 | 33397691 |
| Pubmed | MAP9 MYH11 ABCF1 ATP6V0A1 ANK2 ANK3 SEPTIN4 SYNE1 SPTAN1 NCL FMNL2 UBAP2L EHD1 ITSN2 EIF2S2 MACF1 CTNNA1 KIF5B DMD EIF4G3 PCDH1 UTRN ARHGAP21 WNK2 CA2 | 4.53e-09 | 1431 | 154 | 25 | 37142655 | |
| Pubmed | PRRG1 MAP9 ANK3 CEP162 POLR2B CNTRL DIDO1 ATF2 UBAP2L GPC4 DIAPH1 MACF1 CEP295 BIN2 PLD1 CPSF2 UTRN ZMAT1 ARHGAP21 GOLGB1 AFF4 | 1.54e-08 | 1084 | 154 | 21 | 11544199 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | KRT7 ABCF1 SPTAN1 POLR2B KRI1 DIDO1 NCL PPA1 CHAMP1 NIFK TRMT10C SMC3 UBAP2L RBM19 NAF1 SYNE2 EIF2S2 DIAPH1 EIF5B MACF1 CTNNA1 KIF5B PRKDC GOLGB1 | 1.68e-08 | 1415 | 154 | 24 | 28515276 |
| Pubmed | 2.67e-08 | 151 | 154 | 9 | 17043677 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ABCF1 OFD1 SYNE1 POLR2B NCL MYO5C ACSL3 NIFK SMC3 UBAP2L MYL6B SYNE2 EIF5B MACF1 CTNNA1 KIF5B PRKDC CPSF2 UTRN GOLGB1 | 3.07e-08 | 1024 | 154 | 20 | 24711643 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | ABCF1 NCL CHAMP1 ACSL3 SMC3 UBAP2L SYNE2 GPC4 EIF5B MACF1 CTNNA1 KIF5B EIF4G3 ARHGAP21 | 5.38e-08 | 498 | 154 | 14 | 36634849 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ABCF1 ATP6V0A1 SYNE1 SPTAN1 POLR2B KRI1 NCL PPA1 CCDC38 LARP7 ACSL3 NIFK TRMT10C SMC3 UBAP2L RBM19 EIF2S2 DIAPH1 EIF5B CC2D2A KIF5B PRKDC CA2 | 8.46e-08 | 1425 | 154 | 23 | 30948266 |
| Pubmed | Nesprins anchor kinesin-1 motors to the nucleus to drive nuclear distribution in muscle cells. | 8.51e-08 | 3 | 154 | 3 | 25516977 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CLUAP1 ABCF1 UBAP2 ANK3 MNS1 OFD1 UBE3B PPA1 CCDC122 FMNL2 ACSL3 SMC3 CEP44 MYL6B NAF1 PTPRQ EIF5B ANKRD28 CTNNA1 COA7 CCDC144A PMFBP1 | 9.74e-08 | 1321 | 154 | 22 | 27173435 |
| Pubmed | OFD1 CEP162 SPTAN1 KRI1 ACSL3 SMC3 ANKRD28 CEP295 MPHOSPH9 PRKDC R3HDM1 UTRN COA7 | 1.08e-07 | 446 | 154 | 13 | 24255178 | |
| Pubmed | RAB12 ANK2 ANK3 SMC3 UBAP2L EHD1 EIF5B MACF1 MPHOSPH9 CTNNA1 KIF5B PRKDC EIF4G3 CAMSAP1 ARHGAP21 GOLGB1 | 1.16e-07 | 708 | 154 | 16 | 39231216 | |
| Pubmed | ABCF1 UBAP2 SPTAN1 NCL ACSL3 UBAP2L EHD1 EIF2S2 DIAPH1 MACF1 CTNNA1 KIF5B PRKDC CPSF2 UTRN GOLGB1 | 1.23e-07 | 711 | 154 | 16 | 33022573 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | ABCF1 SYNE1 POLR2B DIDO1 NCL LARP7 NIFK TRMT10C UBAP2L RBM19 NAF1 EIF2S2 EIF5B MACF1 PRKDC R3HDM1 EIF4G3 | 1.24e-07 | 807 | 154 | 17 | 22681889 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYH11 ABCF1 ANK3 SYNE1 SPTAN1 CNTRL NCL PPA1 EIF2S2 DIAPH1 EIF5B MACF1 CTNNA1 PRKDC PALS2 UTRN CA2 | 1.24e-07 | 807 | 154 | 17 | 30575818 |
| Pubmed | DOCK3 ABCF1 UBAP2 ANK2 ANK3 SH3BGRL SPTAN1 ADGRB3 NCL PALMD ACSL3 TRMT10C MICU3 UBAP2L ANKRD28 MACF1 KIF5B EIF4G3 CAMSAP1 WNK2 | 1.71e-07 | 1139 | 154 | 20 | 36417873 | |
| Pubmed | 2.01e-07 | 191 | 154 | 9 | 33762435 | ||
| Pubmed | ANK3 OFD1 CEP162 SPTAN1 POLR2B KRI1 PFDN4 ACSL3 NIFK TRMT10C SYNE2 ANKRD28 MPHOSPH9 CTNNA1 DMD CPSF2 CDC25A STX17 UTRN | 2.23e-07 | 1049 | 154 | 19 | 27880917 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MYH11 MYL1 SWAP70 SPTAN1 ADGRB3 TOMM20 NCL CCDC144CP TRMT10C SMC3 EIF2S2 MACF1 KIF5B PRKDC EIF4G3 UTRN GOLGB1 | 2.45e-07 | 847 | 154 | 17 | 35235311 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | ABCF1 SPTAN1 DIDO1 NCL CHAMP1 SMC3 UBAP2L KIF5B PRKDC TAF1 CPSF2 | 3.04e-07 | 332 | 154 | 11 | 32786267 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | UBAP2 OFD1 CEP162 SPTAN1 MYLK2 SYNE2 FNIP1 MACF1 MPHOSPH9 KIF5B R3HDM1 EIF4G3 CAMSAP1 UTRN ARHGAP21 WNK3 GOLGB1 | 3.08e-07 | 861 | 154 | 17 | 36931259 |
| Pubmed | PRUNE2 ABCF1 MYL1 LARP7 NIFK RBM19 EIF2S2 DIAPH1 EIF5B FNIP1 MACF1 CTNNA1 AFF4 | 3.64e-07 | 496 | 154 | 13 | 31343991 | |
| Pubmed | ANK3 CEP162 CNTRL NCL FMNL2 RBM19 EHD1 ANKRD28 MPHOSPH9 PRKDC PLD1 EIF4G3 CAMSAP1 ZMAT1 ARHGAP21 GOLGB1 | 4.04e-07 | 777 | 154 | 16 | 35844135 | |
| Pubmed | KRT7 ANK3 VPS8 PPARD FMNL2 RBM19 DIAPH1 ANKRD28 MACF1 CAMSAP1 PCDH1 UTRN GOLGB1 ZMYM5 | 4.29e-07 | 591 | 154 | 14 | 15231748 | |
| Pubmed | SPTAN1 POLR2B KRI1 LARP7 SMC3 UBAP2L CTNNA1 CPSF2 R3HDM1 ARHGAP21 | 4.43e-07 | 274 | 154 | 10 | 34244482 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 4.65e-07 | 154 | 154 | 8 | 16055720 | |
| Pubmed | ABCF1 ATP6V0A1 ANK2 ANK3 OFD1 SYNE1 SPTAN1 POLR2B KRI1 NCL LARP7 ACSL3 NIFK TRMT10C SYNE2 EIF5B ANKRD28 MACF1 CTNNA1 EIF4G3 COA7 GOLGB1 | 7.22e-07 | 1487 | 154 | 22 | 33957083 | |
| Pubmed | MYH11 VSNL1 UBAP2 ANK2 SPTAN1 KRI1 DIDO1 NCL FMNL2 LARP7 NIFK TRMT10C UBAP2L RBM19 MYL6B NAF1 EHD1 KIF5B PLD1 CPSF2 AFF4 | 7.63e-07 | 1371 | 154 | 21 | 36244648 | |
| Pubmed | BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates. | 8.24e-07 | 226 | 154 | 9 | 25900982 | |
| Pubmed | An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan. | 8.46e-07 | 5 | 154 | 3 | 19109891 | |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 1.14e-06 | 235 | 154 | 9 | 28378594 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYH11 ABCF1 MYL1 SYNE1 SPTAN1 POLR2B CD109 NCL MYO5C NIFK SMC3 MYL6B EIF2S2 EIF5B CTNNA1 KIF5B PRKDC | 1.17e-06 | 949 | 154 | 17 | 36574265 |
| Pubmed | OFD1 CEP162 SPTAN1 POLR2B RSF1 PPA1 LARP7 ODF2L UBAP2L DIAPH1 MPHOSPH9 KIF5B CAMSAP1 UTRN | 1.20e-06 | 645 | 154 | 14 | 25281560 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ABCF1 OFD1 CEP162 POLR2B CNTRL KRI1 PFDN4 ODF2L MYL6B ITSN2 ANKRD28 CEP295 MPHOSPH9 KIF5B CAMSAP1 ARHGAP21 | 1.37e-06 | 853 | 154 | 16 | 28718761 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | UBAP2 ANK3 SWAP70 SPTAN1 FMNL2 EHD1 MACF1 CTNNA1 KIF5B PCDH1 UTRN ARHGAP21 GOLGB1 | 1.55e-06 | 565 | 154 | 13 | 25468996 |
| Pubmed | ABCF1 UBAP2 ANK2 POLR2B KRI1 NCL PFDN4 USP37 LARP7 NIFK TRMT10C UBAP2L NAF1 EIF2S2 EIF5B CPSF2 CDC25A | 1.60e-06 | 971 | 154 | 17 | 33306668 | |
| Pubmed | In vivo assembly of the axon initial segment in motor neurons. | 1.69e-06 | 6 | 154 | 3 | 23728480 | |
| Pubmed | PPP1R21 SMC3 UBAP2L SYNE2 MACF1 RPRD2 CTNNA1 KIF5B PRKDC DMD | 1.91e-06 | 322 | 154 | 10 | 26514267 | |
| Pubmed | Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice. | 2.94e-06 | 7 | 154 | 3 | 7495297 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 2.96e-06 | 197 | 154 | 8 | 20811636 | |
| Pubmed | RAB12 ATP6V0A1 ANK2 SPTAN1 ADGRB3 TOMM20 UBAP2L MACF1 CTNNA1 EIF4G3 | 3.70e-06 | 347 | 154 | 10 | 17114649 | |
| Pubmed | 4.22e-06 | 146 | 154 | 7 | 21399614 | ||
| Pubmed | KRT7 SWAP70 SPTAN1 DIDO1 MACF1 CTNNA1 KIF5B PRKDC UTRN GOLGB1 | 5.12e-06 | 360 | 154 | 10 | 33111431 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 5.21e-06 | 283 | 154 | 9 | 30585729 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 5.24e-06 | 361 | 154 | 10 | 26167880 | |
| Pubmed | 6.12e-06 | 101 | 154 | 6 | 26949739 | ||
| Pubmed | TBC1D9B SPTAN1 POLR2B VPS8 CD109 KRI1 LARP7 ACSL3 TRMT10C UBAP2L CEP44 MYL6B SYNE2 EHD1 EIF2S2 EIF5B ANKRD28 CTNNA1 PRKDC STX17 | 6.21e-06 | 1440 | 154 | 20 | 30833792 | |
| Pubmed | 6.53e-06 | 156 | 154 | 7 | 22952844 | ||
| Pubmed | UBAP2 ANK3 SWAP70 SPTAN1 POLR2B DIDO1 CHAMP1 UBAP2L RPRD2 KIF5B PRKDC TAF1 | 6.68e-06 | 549 | 154 | 12 | 38280479 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PRUNE2 KRT7 ABCF1 SWAP70 SPTAN1 POLR2B NCL PFDN4 LARP7 TYMS NAF1 EHD1 EIF2S2 DIAPH1 EIF5B ANKRD28 MACF1 CTNNA1 KIF5B PRKDC | 7.23e-06 | 1455 | 154 | 20 | 22863883 |
| Pubmed | 7.25e-06 | 104 | 154 | 6 | 9205841 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ABCF1 POLR2B AGGF1 KRI1 DIDO1 NCL LARP7 NIFK SMC3 UBAP2L EIF2S2 MACF1 PRKDC EIF4G3 | 7.80e-06 | 759 | 154 | 14 | 35915203 |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 8.70e-06 | 163 | 154 | 7 | 22113938 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ABCF1 SPTAN1 POLR2B RSF1 NCL PPA1 ACSL3 NIFK SMC3 RBM19 EHD1 EIF2S2 DIAPH1 EIF5B ANKRD28 MACF1 KIF5B PRKDC UTRN | 9.26e-06 | 1353 | 154 | 19 | 29467282 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ABCF1 SPTAN1 DIDO1 NCL CHAMP1 ATF2 ACSL3 UBAP2L ATXN7 NAF1 EIF5B CTNNA1 PRKDC CPSF2 | 9.72e-06 | 774 | 154 | 14 | 15302935 |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 9.99e-06 | 10 | 154 | 3 | 22159418 | |
| Pubmed | Nesprin 1α2 is essential for mouse postnatal viability and nuclear positioning in skeletal muscle. | 9.99e-06 | 10 | 154 | 3 | 28533284 | |
| Pubmed | TRAF7 POLR2B RSF1 CHAMP1 FMNL2 LARP7 NIFK ATXN7 NAF1 DIAPH1 ANKRD28 MACF1 CEP295 TAF1 PLD1 AFF4 SP140 | 1.00e-05 | 1116 | 154 | 17 | 31753913 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | UBAP2 CETN3 AGGF1 KRI1 PFDN4 USP37 TRMT10C SMC3 NAF1 ANKRD28 MPHOSPH9 KIF5B EIF4G3 CDC25A UTRN CA2 | 1.08e-05 | 1005 | 154 | 16 | 19615732 |
| Pubmed | 1.36e-05 | 116 | 154 | 6 | 21282530 | ||
| Pubmed | 1.37e-05 | 11 | 154 | 3 | 10995443 | ||
| Pubmed | 1.37e-05 | 11 | 154 | 3 | 19270065 | ||
| Pubmed | CFAP47 UBAP2 SPTAN1 NCL PPA1 SMC3 UBAP2L DIAPH1 EIF5B CTNNA1 KIF5B | 1.38e-05 | 494 | 154 | 11 | 26831064 | |
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 1.50e-05 | 118 | 154 | 6 | 27377895 | |
| Pubmed | ABCF1 KRI1 NCL LARP7 TRMT10C SMC3 UBAP2L EIF2S2 EIF5B CTNNA1 KIF5B PRKDC DMD ARHGAP21 | 1.59e-05 | 809 | 154 | 14 | 32129710 | |
| Pubmed | ABCF1 POLR2B DIDO1 NCL FMNL2 NIFK TRMT10C MYL6B EIF2S2 EIF5B MACF1 PRKDC | 1.64e-05 | 601 | 154 | 12 | 33658012 | |
| Pubmed | DNA Damage Regulates Translation through β-TRCP Targeting of CReP. | 1.74e-05 | 35 | 154 | 4 | 26091241 | |
| Pubmed | PPP1R21 ABCF1 OFD1 CNTRL NCL CHST11 ACSL3 GBP5 RBM19 EHD1 MPHOSPH9 KIF5B PRKDC PLD1 CPSF2 ARHGAP45 GOLGB1 | 1.80e-05 | 1168 | 154 | 17 | 19946888 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 10525423 | ||
| Pubmed | In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice. | 1.95e-05 | 2 | 154 | 2 | 28790199 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 25859846 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 30070693 | ||
| Pubmed | G-utrophin, the autosomal homologue of dystrophin Dp116, is expressed in sensory ganglia and brain. | 1.95e-05 | 2 | 154 | 2 | 7731967 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 17668421 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 23772025 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 16710609 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 30672725 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 7962191 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 11792814 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 8021701 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 26494449 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 26974331 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 34100076 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 14992721 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 28453658 | ||
| Pubmed | A quantitative study of bioenergetics in skeletal muscle lacking utrophin and dystrophin. | 1.95e-05 | 2 | 154 | 2 | 11801396 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 7987307 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 1.95e-05 | 2 | 154 | 2 | 24931616 | |
| Pubmed | Comparative analysis of the human dystrophin and utrophin gene structures. | 1.95e-05 | 2 | 154 | 2 | 11861579 | |
| Pubmed | Distinct mechanical properties in homologous spectrin-like repeats of utrophin. | 1.95e-05 | 2 | 154 | 2 | 30914715 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 22284942 | ||
| Pubmed | Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice. | 1.95e-05 | 2 | 154 | 2 | 17889902 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 35557546 | ||
| Pubmed | Characterization of the Ang/Tie2 Signaling Pathway in the Diaphragm Muscle of DMD Mice. | 1.95e-05 | 2 | 154 | 2 | 37626761 | |
| Interaction | PFN1 interactions | MAP9 ANK2 SH3BGRL SPTAN1 NCL FMNL2 ATF2 LARP7 MYO5C CEP44 SYNE2 DIAPH1 DIAPH2 ANKRD28 MACF1 ARHGAP21 GOLGB1 AFF4 | 4.77e-08 | 509 | 150 | 18 | int:PFN1 |
| Interaction | PCNT interactions | OFD1 CEP162 SYNE1 SPTAN1 CNTRL ODF2L CEP44 MACF1 MPHOSPH9 EIF4G3 UTRN ARHGAP21 | 2.62e-07 | 241 | 150 | 12 | int:PCNT |
| Interaction | LCA5 interactions | 4.04e-07 | 125 | 150 | 9 | int:LCA5 | |
| Interaction | EZR interactions | ANK2 ANK3 SWAP70 SPTAN1 PALMD MYO5C MYLK4 ITSN2 PTPRQ EIF2S2 ANKRD28 MACF1 CTNNA1 EIF4G3 UTRN ARHGAP21 GOLGB1 | 8.21e-07 | 553 | 150 | 17 | int:EZR |
| Interaction | NAA40 interactions | ABCF1 UBAP2 ANK2 RSF1 DIDO1 NCL PPA1 CHAMP1 UBAP2L CEP44 NAF1 EIF5B ANKRD28 MACF1 RPRD2 KIF5B PRKDC EIF4G3 CAMSAP1 UTRN ARHGAP21 GOLGB1 AFF4 | 9.50e-07 | 978 | 150 | 23 | int:NAA40 |
| Interaction | MED4 interactions | MYH11 OFD1 CEP162 SPTAN1 POLR2B CNTRL LARP7 NIFK ODF2L UBAP2L RPRD2 MPHOSPH9 KIF5B CAMSAP1 UTRN | 1.40e-06 | 450 | 150 | 15 | int:MED4 |
| Interaction | ANKRD28 interactions | ANK2 ANK3 CEP162 CNTRL KRI1 SMC3 CEP44 ANKRD28 CTNNA1 PRKDC CDC25A | 1.54e-06 | 235 | 150 | 11 | int:ANKRD28 |
| Interaction | CIT interactions | MYH11 ABCF1 SYNE1 SPTAN1 POLR2B RSF1 CD109 KRI1 DIDO1 NCL PPA1 CHAMP1 ACSL3 NIFK TRMT10C SMC3 UBAP2L RBM19 MYL6B SYNE2 EIF2S2 EIF5B MACF1 CTNNA1 PRKDC CPSF2 CDC25A CCDC180 | 2.75e-06 | 1450 | 150 | 28 | int:CIT |
| Interaction | SIRT7 interactions | ABCF1 SPTAN1 RSF1 KRI1 DIDO1 NCL LARP7 ACSL3 NIFK UBAP2L SYNE2 EIF5B ANKRD28 MACF1 CTNNA1 KIF5B PRKDC EIF4G3 UTRN | 2.83e-06 | 744 | 150 | 19 | int:SIRT7 |
| Interaction | ODF2 interactions | TRAF7 OFD1 CNTRL ODF2L CEP44 ANKRD28 MPHOSPH9 CAMSAP1 ARHGAP21 | 2.88e-06 | 158 | 150 | 9 | int:ODF2 |
| Interaction | OBSL1 interactions | PRUNE2 ABCF1 MYL1 SYNE1 POLR2B NCL LARP7 ACSL3 NIFK SMC3 UBAP2L RBM19 SYNE2 EIF5B FNIP1 MACF1 CTNNA1 PRKDC CPSF2 UTRN GOLGB1 | 3.48e-06 | 902 | 150 | 21 | int:OBSL1 |
| Interaction | OTUD7A interactions | 4.52e-06 | 58 | 150 | 6 | int:OTUD7A | |
| Interaction | RHOD interactions | ANK3 CETN3 SPTAN1 PPA1 FMNL2 ACSL3 TRMT10C MYL6B SYNE2 DIAPH1 DIAPH2 MACF1 CTNNA1 UTRN ARHGAP21 GOLGB1 | 5.89e-06 | 572 | 150 | 16 | int:RHOD |
| Interaction | CEP135 interactions | OFD1 CEP162 ODF2L CEP44 ANKRD28 CEP295 MPHOSPH9 PLD1 CAMSAP1 ARHGAP21 GOLGB1 | 6.29e-06 | 272 | 150 | 11 | int:CEP135 |
| Interaction | PHLPP1 interactions | KRT7 ABCF1 UBAP2 SWAP70 SPTAN1 KRI1 DIDO1 UBAP2L EIF5B KIF5B PRKDC GOLGB1 | 7.64e-06 | 333 | 150 | 12 | int:PHLPP1 |
| Interaction | MTNR1B interactions | 7.79e-06 | 135 | 150 | 8 | int:MTNR1B | |
| Interaction | ECT2 interactions | RAB12 MYH11 ABCF1 OFD1 SPTAN1 CD109 AGGF1 KRI1 NCL MYO5C ACSL3 NIFK MYL6B EIF5B GPSM2 MACF1 PRKDC CPSF2 DNAH9 ARHGAP21 | 9.74e-06 | 887 | 150 | 20 | int:ECT2 |
| Interaction | DMD interactions | 1.07e-05 | 141 | 150 | 8 | int:DMD | |
| Interaction | CTNNA1 interactions | ANK3 SPTAN1 FMNL2 PTPRQ ANKRD28 MACF1 CTNNA1 DMD STX17 CCDC180 UTRN ARHGAP21 | 1.16e-05 | 347 | 150 | 12 | int:CTNNA1 |
| Interaction | SEPTIN10 interactions | 1.25e-05 | 144 | 150 | 8 | int:SEPTIN10 | |
| Interaction | SPICE1 interactions | MAP9 OFD1 CEP162 CEP44 GPC4 CEP295 MPHOSPH9 CAMSAP1 ARHGAP21 | 1.34e-05 | 191 | 150 | 9 | int:SPICE1 |
| Interaction | CEP120 interactions | 1.45e-05 | 106 | 150 | 7 | int:CEP120 | |
| Interaction | CDH1 interactions | UBAP2 ANK3 SWAP70 SPTAN1 FMNL2 NFE2L2 EHD1 PTPRQ DIAPH1 MACF1 CTNNA1 KIF5B PRKDC STX17 PCDH1 UTRN ARHGAP21 GOLGB1 | 1.69e-05 | 768 | 150 | 18 | int:CDH1 |
| Interaction | SNCA interactions | ABCF1 SEPTIN4 TOMM20 NCL CHAMP1 ACSL3 UBAP2L SYNE2 GPC4 EIF5B MACF1 CEP295 CTNNA1 KIF5B PLD1 EIF4G3 ARHGAP21 | 2.50e-05 | 716 | 150 | 17 | int:SNCA |
| Interaction | FGD5 interactions | 2.54e-05 | 207 | 150 | 9 | int:FGD5 | |
| Interaction | KCTD13 interactions | MAP9 MYH11 ABCF1 ATP6V0A1 ANK2 ANK3 SEPTIN4 SYNE1 SPTAN1 NCL FMNL2 UBAP2L EHD1 ITSN2 EIF2S2 MACF1 CTNNA1 KIF5B DMD EIF4G3 PCDH1 UTRN ARHGAP21 WNK2 CA2 | 3.55e-05 | 1394 | 150 | 25 | int:KCTD13 |
| Interaction | APC interactions | MYH11 SYNE1 TOMM20 PPARD SMC3 DIAPH1 ANKRD28 MACF1 CTNNA1 KIF5B TAF1 ARHGAP21 | 3.56e-05 | 389 | 150 | 12 | int:APC |
| Interaction | CEP162 interactions | 3.80e-05 | 168 | 150 | 8 | int:CEP162 | |
| Interaction | NINL interactions | ABCF1 OFD1 CEP162 ODF2L ITSN2 CC2D2A RPRD2 CEP295 MPHOSPH9 PRKDC CAMSAP1 ARHGAP21 CA2 | 3.96e-05 | 458 | 150 | 13 | int:NINL |
| Interaction | BORCS6 interactions | 4.14e-05 | 170 | 150 | 8 | int:BORCS6 | |
| Interaction | H3C1 interactions | ANK2 ANK3 SYNE1 SPTAN1 RSF1 KRI1 DIDO1 CHAMP1 LARP7 MYLK2 TYMS SMC3 NFE2L2 BIN2 PRKDC TAF1 CAMSAP1 DNAH9 AFF4 | 4.14e-05 | 901 | 150 | 19 | int:H3C1 |
| Interaction | RAC2 interactions | TRAF7 ATP6V0A1 SWAP70 SPTAN1 PPA1 ACSL3 TRMT10C SYNE2 EHD1 DIAPH2 MACF1 CTNNA1 PLD1 UTRN ARHGAP21 GOLGB1 | 4.39e-05 | 674 | 150 | 16 | int:RAC2 |
| Interaction | RPGRIP1L interactions | 4.88e-05 | 225 | 150 | 9 | int:RPGRIP1L | |
| Interaction | CEP63 interactions | 5.96e-05 | 179 | 150 | 8 | int:CEP63 | |
| Interaction | EFTUD2 interactions | ABCF1 SPTAN1 KRI1 DIDO1 NCL PPA1 USP37 CHAMP1 LARP7 NIFK TRMT10C SMC3 UBAP2L RBM19 NAF1 SYNE2 EIF2S2 DIAPH1 EIF5B MACF1 CTNNA1 KIF5B PRKDC CPSF2 GOLGB1 | 6.66e-05 | 1449 | 150 | 25 | int:EFTUD2 |
| Interaction | BTRC interactions | UBAP2 OFD1 POLR2B NCL PFDN4 USP37 UBAP2L NFE2L2 RBM19 CEP44 EIF2S2 BTG3 FNIP1 RPRD2 CTNNA1 CDC25A CCDC180 | 6.69e-05 | 775 | 150 | 17 | int:BTRC |
| Interaction | AGR2 interactions | MYH11 ABCF1 ANK3 CETN3 SYNE1 SPTAN1 CNTRL NCL PPA1 EIF2S2 DIAPH1 EIF5B GPSM2 MACF1 CTNNA1 PRKDC PALS2 UTRN CA2 | 6.70e-05 | 934 | 150 | 19 | int:AGR2 |
| Interaction | KDM1A interactions | KRT7 MNS1 OFD1 CEP162 POLR2B TDO2 PPARD CHAMP1 NFE2L2 CEP44 ITSN2 ANKRD28 KIF5B TAF1 CPSF2 CAMSAP1 UTRN ARHGAP21 GOLGB1 | 7.39e-05 | 941 | 150 | 19 | int:KDM1A |
| Interaction | KCNA3 interactions | RAB12 ANK2 ANK3 CCDC73 MYO5C SMC3 UBAP2L EHD1 EIF5B MACF1 MPHOSPH9 CTNNA1 KIF5B PRKDC EIF4G3 CAMSAP1 ARHGAP21 GOLGB1 | 8.65e-05 | 871 | 150 | 18 | int:KCNA3 |
| Interaction | DISC1 interactions | MNS1 OFD1 SYNE1 SPTAN1 LARP7 SMC3 UBAP2L CEP44 ANKRD28 MACF1 DMD UTRN | 9.09e-05 | 429 | 150 | 12 | int:DISC1 |
| Interaction | TXLNG interactions | 9.22e-05 | 98 | 150 | 6 | int:TXLNG | |
| Interaction | TNIP1 interactions | MYH11 ABCF1 MYL1 OFD1 SYNE1 SPTAN1 POLR2B CD109 NCL MYO5C NIFK SMC3 CEP44 MYL6B EIF2S2 GPC4 EIF5B CTNNA1 KIF5B PRKDC DMD CA2 | 9.85e-05 | 1217 | 150 | 22 | int:TNIP1 |
| Interaction | RAB35 interactions | ANK3 SPTAN1 CNTRL FMNL2 ACSL3 SYNE2 EHD1 DIAPH1 MACF1 CTNNA1 PLD1 UTRN ARHGAP21 GOLGB1 | 9.96e-05 | 573 | 150 | 14 | int:RAB35 |
| Interaction | EIF3G interactions | 1.06e-04 | 249 | 150 | 9 | int:EIF3G | |
| Interaction | CHMP4B interactions | MYH11 ATP6V0A1 OFD1 SPTAN1 CD109 NCL ACSL3 SMC3 MYL6B EIF2S2 PRKDC TAF1 PALS2 ARHGAP21 GOLGB1 PMFBP1 | 1.07e-04 | 727 | 150 | 16 | int:CHMP4B |
| Interaction | H2BC9 interactions | ABCF1 SPTAN1 TEX15 LARP7 SMC3 NFE2L2 GPC4 DIAPH1 CDC25A MAML3 AFF4 CCDC63 | 1.31e-04 | 446 | 150 | 12 | int:H2BC9 |
| Interaction | HECTD1 interactions | ABCF1 POLR2B AGGF1 KRI1 DIDO1 NCL LARP7 MYO5C NIFK SMC3 UBAP2L EIF2S2 ANKRD28 MACF1 PRKDC TAF1 CPSF2 EIF4G3 UTRN | 1.33e-04 | 984 | 150 | 19 | int:HECTD1 |
| Interaction | SUMO2 interactions | ABCF1 SPTAN1 DIDO1 NCL CHAMP1 SMC3 UBAP2L ATXN7 NFE2L2 KIF5B PRKDC TAF1 CPSF2 ZMYM5 | 1.38e-04 | 591 | 150 | 14 | int:SUMO2 |
| Interaction | MYO1E interactions | 1.38e-04 | 202 | 150 | 8 | int:MYO1E | |
| Interaction | CEP170 interactions | PPP1R21 CLUAP1 OFD1 CEP162 CNTRL NCL SMC3 CEP44 SYNE2 CAMSAP1 | 1.39e-04 | 318 | 150 | 10 | int:CEP170 |
| Interaction | GLDC interactions | SPTAN1 POLR2B KRI1 LARP7 SMC3 UBAP2L CTNNA1 CPSF2 R3HDM1 ARHGAP21 | 1.50e-04 | 321 | 150 | 10 | int:GLDC |
| Interaction | RHOF interactions | ATP6V0A1 ANK3 SPTAN1 ACSL3 TRMT10C MYL6B EHD1 DIAPH1 DIAPH2 MACF1 CTNNA1 PRKDC UTRN ARHGAP21 GOLGB1 | 1.54e-04 | 673 | 150 | 15 | int:RHOF |
| Interaction | KIAA0753 interactions | 1.77e-04 | 157 | 150 | 7 | int:KIAA0753 | |
| Interaction | GPATCH1 interactions | 1.83e-04 | 111 | 150 | 6 | int:GPATCH1 | |
| Interaction | H1-5 interactions | SYNE1 CNTRL RSF1 TOMM20 NCL LARP7 RBM19 SCN4A RPRD2 WNK3 AFF4 SP140 | 1.85e-04 | 463 | 150 | 12 | int:H1-5 |
| Interaction | TES interactions | KRT7 SH3BGRL SPTAN1 MYLK2 ACSL3 DIAPH1 MACF1 CTNNA1 PRKDC UTRN | 1.96e-04 | 332 | 150 | 10 | int:TES |
| Interaction | WDR5 interactions | CLUAP1 ABCF1 UBAP2 SPTAN1 POLR2B NCL PFDN4 ACSL3 UBAP2L EHD1 EIF2S2 DIAPH1 MACF1 CTNNA1 KIF5B PRKDC TAF1 CPSF2 UTRN GOLGB1 | 1.97e-04 | 1101 | 150 | 20 | int:WDR5 |
| Interaction | YWHAH interactions | MYH11 UBAP2 OFD1 CEP162 SPTAN1 CNTRL SYNE2 CC2D2A FNIP1 MACF1 MPHOSPH9 KIF5B R3HDM1 EIF4G3 CAMSAP1 CDC25A UTRN ARHGAP21 WNK3 WNK2 | 2.00e-04 | 1102 | 150 | 20 | int:YWHAH |
| Interaction | TMOD1 interactions | 2.06e-04 | 161 | 150 | 7 | int:TMOD1 | |
| Interaction | KIF23 interactions | MYH11 ABCF1 SPTAN1 RSF1 CD109 KRI1 NCL MYO5C ACSL3 NIFK TRMT10C EIF2S2 EIF5B MACF1 PRKDC DMD EIF4G3 ARHGAP21 AFF4 | 2.40e-04 | 1031 | 150 | 19 | int:KIF23 |
| Interaction | KRT19 interactions | 2.69e-04 | 282 | 150 | 9 | int:KRT19 | |
| Interaction | CAMSAP2 interactions | 2.77e-04 | 169 | 150 | 7 | int:CAMSAP2 | |
| Interaction | KIF20A interactions | RAB12 MYH11 ABCF1 ANK2 SYNE1 SPTAN1 CD109 DIDO1 NCL NIFK UBAP2L RBM19 MYL6B SYNE2 MACF1 PRKDC CPSF2 STX17 UTRN | 3.10e-04 | 1052 | 150 | 19 | int:KIF20A |
| Interaction | LYN interactions | PRUNE2 ANK2 ANK3 SPTAN1 FMNL2 LARP7 ACSL3 MACF1 CTNNA1 PRKDC PLD1 DMD PALS2 UTRN ARHGAP21 | 3.18e-04 | 720 | 150 | 15 | int:LYN |
| Interaction | DAXX interactions | 3.20e-04 | 353 | 150 | 10 | int:DAXX | |
| Interaction | CDC42 interactions | TRAF7 ATP6V0A1 ANK3 SYNE1 SPTAN1 NCL PPA1 FMNL2 TYMS ACSL3 TRMT10C MYL6B SYNE2 DIAPH1 DIAPH2 EIF5B CTNNA1 PRKDC PLD1 UTRN ARHGAP21 GOLGB1 | 3.21e-04 | 1323 | 150 | 22 | int:CDC42 |
| Interaction | RAC1 interactions | DOCK3 TRAF7 ANK3 SWAP70 SPTAN1 UBE3B NCL PPA1 FMNL2 ACSL3 TRMT10C MYL6B DIAPH1 DIAPH2 MACF1 CTNNA1 PLD1 UTRN ARHGAP21 | 3.52e-04 | 1063 | 150 | 19 | int:RAC1 |
| Interaction | PXDNL interactions | 3.59e-04 | 19 | 150 | 3 | int:PXDNL | |
| Interaction | EPB42 interactions | 3.59e-04 | 19 | 150 | 3 | int:EPB42 | |
| Interaction | BIRC3 interactions | ABCF1 SEPTIN4 SYNE1 SPTAN1 POLR2B KRI1 NCL PPA1 CCDC38 ACSL3 NIFK TRMT10C SMC3 UBAP2L RBM19 EIF2S2 DIAPH1 EIF5B CC2D2A KIF5B PRKDC CA2 | 3.60e-04 | 1334 | 150 | 22 | int:BIRC3 |
| Interaction | HAUS8 interactions | 3.79e-04 | 127 | 150 | 6 | int:HAUS8 | |
| Interaction | CEP128 interactions | OFD1 CEP162 CNTRL ODF2L CEP44 ANKRD28 MPHOSPH9 CAMSAP1 ARHGAP21 | 3.93e-04 | 297 | 150 | 9 | int:CEP128 |
| Interaction | CCDC14 interactions | 4.12e-04 | 129 | 150 | 6 | int:CCDC14 | |
| Interaction | GRK5 interactions | 4.34e-04 | 182 | 150 | 7 | int:GRK5 | |
| Interaction | RAB11A interactions | SWAP70 SPTAN1 VPS8 KRI1 ATF2 MYO5C ACSL3 NIFK SMC3 SYNE2 EHD1 EIF2S2 DIAPH2 KIF5B PLD1 GOLGB1 | 4.71e-04 | 830 | 150 | 16 | int:RAB11A |
| Interaction | KRT8 interactions | KRT7 OFD1 CEP162 ATF2 CEP44 SCN4A ANKRD28 MPHOSPH9 DMD CAMSAP1 ARHGAP21 | 4.75e-04 | 441 | 150 | 11 | int:KRT8 |
| Interaction | MAPRE1 interactions | MAP9 OFD1 CEP162 SPTAN1 CD109 EIF2S2 DIAPH1 EIF5B MACF1 CTNNA1 CAMSAP1 ARHGAP21 | 4.76e-04 | 514 | 150 | 12 | int:MAPRE1 |
| Interaction | SPTB interactions | 4.83e-04 | 87 | 150 | 5 | int:SPTB | |
| Interaction | RHOQ interactions | TRAF7 ATP6V0A1 SPTAN1 PPA1 EHD1 DIAPH2 CTNNA1 PLD1 UTRN ARHGAP21 GOLGB1 | 4.84e-04 | 442 | 150 | 11 | int:RHOQ |
| Interaction | SYNGAP1 interactions | 5.00e-04 | 307 | 150 | 9 | int:SYNGAP1 | |
| Interaction | YAP1 interactions | PRRG1 MYH11 UBAP2 ANK3 SWAP70 SPTAN1 POLR2B DIDO1 NCL CHAMP1 UBAP2L MYL6B GPC4 RPRD2 CTNNA1 KIF5B PRKDC TAF1 ARHGAP45 | 5.08e-04 | 1095 | 150 | 19 | int:YAP1 |
| Interaction | LRRC74A interactions | 5.42e-04 | 5 | 150 | 2 | int:LRRC74A | |
| Interaction | NDC80 interactions | 5.61e-04 | 312 | 150 | 9 | int:NDC80 | |
| Interaction | MARCKS interactions | ANK2 ANK3 SWAP70 SPTAN1 ATF2 LARP7 ACSL3 MYLK4 MACF1 CTNNA1 PLD1 DMD UTRN | 5.69e-04 | 601 | 150 | 13 | int:MARCKS |
| Interaction | CEP126 interactions | 5.94e-04 | 91 | 150 | 5 | int:CEP126 | |
| Interaction | PABPN1 interactions | 5.97e-04 | 192 | 150 | 7 | int:PABPN1 | |
| Interaction | FGFR3 interactions | 6.01e-04 | 315 | 150 | 9 | int:FGFR3 | |
| Interaction | CFTR interactions | PPP1R21 CFAP47 KRT7 MYH11 TBC1D9B SPTAN1 TOMM20 NCL PPA1 MYLK2 ACSL3 NFIL3 EHD1 EIF2S2 DIAPH1 FNIP1 MACF1 SERAC1 CTNNA1 KIF5B PRKDC MTFR2 DMD | 6.01e-04 | 1480 | 150 | 23 | int:CFTR |
| Interaction | RAD18 interactions | SPTAN1 RSF1 NCL CHAMP1 ATF2 ACSL3 EIF2S2 CTNNA1 PRKDC CPSF2 UTRN | 6.38e-04 | 457 | 150 | 11 | int:RAD18 |
| Interaction | TEX15 interactions | 6.42e-04 | 23 | 150 | 3 | int:TEX15 | |
| Interaction | CAPN6 interactions | 6.42e-04 | 23 | 150 | 3 | int:CAPN6 | |
| Interaction | CDC5L interactions | SYNE1 SPTAN1 NCL LARP7 MYLK2 TRMT10C SMC3 EHD1 EIF2S2 DIAPH1 MACF1 CTNNA1 KIF5B PRKDC CPSF2 GOLGB1 | 6.49e-04 | 855 | 150 | 16 | int:CDC5L |
| Interaction | ST13 interactions | 6.54e-04 | 195 | 150 | 7 | int:ST13 | |
| GeneFamily | EF-hand domain containing | TBC1D9B VSNL1 MYL1 CALB2 SWAP70 CETN3 SPTAN1 MICU3 MYL6B EHD1 ITSN2 MACF1 TNNC1 | 8.13e-11 | 219 | 92 | 13 | 863 |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 1.53e-04 | 4 | 92 | 2 | 1252 | |
| GeneFamily | PHD finger proteins | 1.15e-03 | 90 | 92 | 4 | 88 | |
| GeneFamily | Basic leucine zipper proteins | 1.98e-03 | 49 | 92 | 3 | 506 | |
| GeneFamily | Myosin light chains|EF-hand domain containing | 2.24e-03 | 14 | 92 | 2 | 657 | |
| Coexpression | GABRIELY_MIR21_TARGETS | CNTRL RSF1 ATF2 SYNE2 ITSN2 ANKRD28 SERAC1 TAF1 PLD1 DMD CDC25A UTRN ARHGAP21 WNK3 | 1.74e-09 | 289 | 153 | 14 | M2196 |
| Coexpression | EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION | 3.59e-07 | 48 | 153 | 6 | M16123 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | OFD1 EMB SYNE1 SH3BGRL SPTAN1 POLR2B CNTRL RSF1 AGGF1 KRI1 CHST11 ATF2 TRANK1 GBP5 SMC3 ATXN7 EHD1 ITSN2 DIAPH1 ANKRD28 MACF1 BIN2 ARHGAP45 UTRN ZMYM5 SP140 | 5.25e-07 | 1492 | 153 | 26 | M40023 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | AGGF1 PFDN4 TYMS NIFK ODF2L SMC3 EIF2S2 EIF5B BTG3 GPSM2 KIF5B PRKDC MTFR2 CPSF2 COA7 AFF4 | 1.25e-06 | 644 | 153 | 16 | M10501 |
| Coexpression | GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN | SH3BGRL TRANK1 UBAP2L SYNE2 EHD1 RPRD2 ARHGAP45 CCDC180 ZMAT1 | 2.83e-06 | 200 | 153 | 9 | M8620 |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | MAP9 ATP6V0A1 SWAP70 DIAPH2 EIF5B MPHOSPH9 DMD PALS2 CAMSAP1 AFF4 | 4.34e-06 | 269 | 153 | 10 | M41203 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | MNS1 CETN3 SH3BGRL RSF1 AGGF1 NCL LARP7 TRMT10C SMC3 SYNE2 ITSN2 EIF2S2 EIF5B KIF5B GOLGB1 | 7.41e-06 | 656 | 153 | 15 | M18979 |
| Coexpression | GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN | 2.16e-05 | 197 | 153 | 8 | M5475 | |
| Coexpression | GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_DN | 2.40e-05 | 200 | 153 | 8 | M8558 | |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_DN | 2.40e-05 | 200 | 153 | 8 | M8618 | |
| Coexpression | GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_DN | 2.40e-05 | 200 | 153 | 8 | M6372 | |
| Coexpression | GSE7852_TREG_VS_TCONV_LN_UP | 2.40e-05 | 200 | 153 | 8 | M5727 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | PRRG1 VSNL1 CETN3 POLR2B TOMM20 PFDN4 TYMS ACSL3 ITSN2 MACF1 CTNNA1 PRKDC | 2.72e-05 | 481 | 153 | 12 | M3898 |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_DN | RAB12 UBAP2 MNS1 CETN3 POLR2B USP37 ATF2 TYMS SMC3 BTG3 GPSM2 ANKRD28 MPHOSPH9 PRKDC PALS2 ZMYM5 | 5.74e-05 | 877 | 153 | 16 | M2241 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | POLR2B NCL PFDN4 TDO2 PPA1 THUMPD2 FMNL2 TYMS NIFK GBP5 UBAP2L EIF2S2 BTG3 GPSM2 MPHOSPH9 PRKDC MTFR2 DMD R3HDM1 CDC25A COA7 | 7.21e-05 | 1407 | 153 | 21 | M14427 |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP | 9.35e-05 | 180 | 153 | 7 | M8127 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 1.15e-04 | 250 | 153 | 8 | M11318 | |
| Coexpression | PATIL_LIVER_CANCER | ABCF1 UBE3B CD109 DIDO1 MYO5C TYMS UBAP2L GPSM2 RPRD2 MPHOSPH9 PRKDC CPSF2 CDC25A | 1.39e-04 | 660 | 153 | 13 | M1195 |
| Coexpression | FARMER_BREAST_CANCER_APOCRINE_VS_BASAL | 1.42e-04 | 329 | 153 | 9 | M2631 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_MYELOID_LEUKOCYTE_AGEING | 1.51e-04 | 46 | 153 | 4 | MM3755 | |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 1.51e-04 | 86 | 153 | 5 | M39248 | |
| Coexpression | HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_DN | 1.64e-04 | 47 | 153 | 4 | M40911 | |
| Coexpression | GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN | 1.69e-04 | 198 | 153 | 7 | M8169 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_UP | 1.74e-04 | 199 | 153 | 7 | M5976 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN | 1.74e-04 | 199 | 153 | 7 | M3191 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_UP | 1.80e-04 | 200 | 153 | 7 | M9455 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN | 1.80e-04 | 200 | 153 | 7 | M8048 | |
| Coexpression | GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_UP | 1.80e-04 | 200 | 153 | 7 | M9333 | |
| Coexpression | GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN | 1.80e-04 | 200 | 153 | 7 | M3414 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_DN | 1.80e-04 | 200 | 153 | 7 | M9928 | |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_UP | 1.80e-04 | 200 | 153 | 7 | M8614 | |
| Coexpression | GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN | 1.80e-04 | 200 | 153 | 7 | M9260 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_ENDOTHELIAL_CELL_AGEING | 2.14e-04 | 145 | 153 | 6 | MM3744 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ABCF1 ATP6V0A1 ANK2 MNS1 SH3BGRL CNTRL RSF1 NCL PPA1 CCDC38 FMNL2 LARP7 ODF2L TRMT10C SMC3 NAF1 SYNE2 EIF2S2 DIAPH2 EIF5B GPSM2 ANKRD28 MACF1 CEP295 MTFR2 DMD CPSF2 R3HDM1 CAMSAP1 ARHGAP21 WNK3 ZMYM5 CA2 | 5.86e-11 | 1257 | 152 | 33 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | DOCK3 ABCF1 ATP6V0A1 ANK2 MNS1 EMB SH3BGRL CNTRL RSF1 NCL PPA1 CCDC38 FMNL2 LARP7 ODF2L TRMT10C SMC3 NAF1 SYNE2 EIF2S2 DIAPH2 EIF5B GPSM2 ANKRD28 MACF1 CEP295 MTFR2 DMD CPSF2 R3HDM1 CAMSAP1 ARHGAP21 WNK3 ZMYM5 CA2 | 1.61e-10 | 1459 | 152 | 35 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | PPP1R21 ABCF1 MNS1 CEP162 SH3BGRL ADGRB3 NCL FMNL2 ATF2 ODF2L FUT11 SMC3 SYNE2 EIF2S2 CC2D2A FNIP1 SERAC1 CEP295 MPHOSPH9 PRKDC DMD CAMSAP1 STX17 ARHGAP21 AFF4 ZMYM5 | 2.20e-10 | 831 | 152 | 26 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | PRRG1 MNS1 OFD1 SH3BGRL POLR2B CNTRL RSF1 NCL CCDC122 CCDC38 FUT11 TRMT10C SMC3 UBAP2L NFE2L2 NAF1 SYNE2 MYLK4 EIF2S2 DIAPH2 EIF5B GPSM2 CEP295 MTFR2 TNNC1 R3HDM1 CAMSAP1 WNK3 ZMYM5 CA2 | 4.34e-09 | 1252 | 152 | 30 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | ABCF1 ANK3 MNS1 OFD1 EMB SH3BGRL CNTRL RSF1 TOMM20 NCL PFDN4 PPA1 CCDC122 CCDC38 FUT11 TRMT10C SMC3 NAF1 EIF2S2 DIAPH2 EIF5B MACF1 CEP295 KIF5B MTFR2 PALS2 R3HDM1 ZMYM5 CA2 | 1.44e-08 | 1241 | 152 | 29 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | ABCF1 ATP6V0A1 MNS1 CEP162 SH3BGRL NCL ATF2 FUT11 NFE2L2 SYNE2 ITSN2 CC2D2A FNIP1 MACF1 SERAC1 MPHOSPH9 R3HDM1 CAMSAP1 STX17 MAML3 AFF4 ZMYM5 | 4.01e-08 | 780 | 152 | 22 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | DOCK3 ABCF1 ANK3 MNS1 OFD1 EMB SH3BGRL CNTRL RSF1 TOMM20 NCL PFDN4 PPA1 CCDC122 CCDC38 FUT11 TRMT10C SMC3 NAF1 EIF2S2 DIAPH2 EIF5B MACF1 CEP295 KIF5B MTFR2 PALS2 R3HDM1 ZMYM5 CA2 | 1.52e-07 | 1468 | 152 | 30 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | ABCF1 MNS1 CEP162 NCL ODF2L FUT11 SMC3 SYNE2 EIF2S2 CEP295 MPHOSPH9 PRKDC ARHGAP21 | 3.94e-07 | 311 | 152 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | ABCF1 MNS1 RSF1 NCL FUT11 SMC3 EIF2S2 EIF5B ANKRD28 MPHOSPH9 KIF5B PRKDC PALS2 TNNC1 MAML3 | 1.46e-06 | 469 | 152 | 15 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ABCF1 MNS1 SPTAN1 RSF1 NCL USP37 LARP7 SMC3 EIF2S2 EIF5B ANKRD28 MPHOSPH9 PRKDC PALS2 MAML3 | 6.77e-06 | 532 | 152 | 15 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | ABCF1 ANK2 MNS1 EMB CEP162 CNTRL ODF2L SMC3 SYNE2 MYLK4 EIF2S2 DIAPH2 GPSM2 MACF1 CEP295 MTFR2 DMD R3HDM1 CAMSAP1 WNK3 WNK2 ZMYM5 | 6.81e-06 | 1060 | 152 | 22 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | DOCK3 ABCF1 ANK2 MNS1 EMB CEP162 CNTRL IRAG1 MYO5C ODF2L GBP5 SMC3 SYNE2 MYLK4 EIF2S2 DIAPH2 GPSM2 MACF1 CEP295 MTFR2 DMD R3HDM1 CAMSAP1 WNK3 WNK2 ZMYM5 | 8.05e-06 | 1414 | 152 | 26 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | PPP1R21 ABCF1 MNS1 NCL FUT11 NFE2L2 MACF1 MPHOSPH9 MAML3 AFF4 ZMYM5 | 8.30e-06 | 291 | 152 | 11 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | KRT7 MNS1 NCL ITSN2 EIF2S2 GPSM2 MACF1 MPHOSPH9 TNNC1 MAML3 GOLGB1 | 1.04e-05 | 298 | 152 | 11 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | MNS1 POLR2B DIDO1 NCL ODF2L FUT11 SMC3 UBAP2L SYNE2 EIF2S2 MACF1 CEP295 TAF1 DMD MAML3 GOLGB1 | 1.20e-05 | 629 | 152 | 16 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | DOCK3 ABCF1 ANK2 MNS1 CEP162 SPTAN1 CNTRL RSF1 CNBD2 USP37 CCDC38 FMNL2 LARP7 ODF2L SMC3 SYNE2 EIF2S2 DIAPH2 GPSM2 CEP295 DMD CAMSAP1 ARHGAP21 WNK3 WNK2 | 1.40e-05 | 1370 | 152 | 25 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.61e-05 | 203 | 152 | 9 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | KRT7 ABCF1 MNS1 EMB NCL FUT11 SYNE2 MACF1 MPHOSPH9 TNNC1 UTRN MAML3 CCDC63 | 5.56e-05 | 492 | 152 | 13 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | KRT7 MNS1 SYNE1 NCL FUT11 SMC3 NFE2L2 EIF2S2 MACF1 CEP295 MAML3 GOLGB1 | 6.75e-05 | 432 | 152 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 7.46e-05 | 192 | 152 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 7.46e-05 | 192 | 152 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | ABCF1 MNS1 EMB CEP162 ADGRB3 NCL ODF2L FUT11 SMC3 SYNE2 EIF2S2 CEP295 MPHOSPH9 PRKDC DMD COA7 MAML3 ARHGAP21 WNK2 | 8.60e-05 | 989 | 152 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | RAB12 KRT7 MNS1 SYNE1 NCL FUT11 SMC3 NFE2L2 SYNE2 EIF2S2 DIAPH1 MACF1 CEP295 TAF1 TNNC1 MAML3 GOLGB1 CCDC63 CA2 | 8.60e-05 | 989 | 152 | 19 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.07e-04 | 259 | 152 | 9 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.14e-04 | 204 | 152 | 8 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_1000 | C12orf71 SWAP70 SEPTIN4 SYNE1 SPTAN1 PALMD FMNL2 GBP5 NFE2L2 ITSN2 FNIP1 ANKRD28 MACF1 PCDH1 UTRN CA2 SP140 | 1.29e-04 | 850 | 152 | 17 | gudmap_kidney_adult_RenMedVasc_Tie2_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 2.74e-04 | 232 | 152 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.53e-04 | 241 | 152 | 8 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k1 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | 4.68e-04 | 385 | 152 | 10 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_200 | 5.82e-04 | 143 | 152 | 6 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | KRT7 MYH11 VSNL1 MNS1 PALMD TEX15 FMNL2 FUT11 TRANK1 GPC4 CC2D2A PLD1 STX17 WNK3 SP140 | 6.14e-04 | 797 | 152 | 15 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SYNE1 CNTRL PALMD GBP5 SMC3 SYNE2 ITSN2 DIAPH1 DIAPH2 BTG3 UTRN | 3.35e-11 | 178 | 154 | 11 | 01dafd19de04eff459253eaa9a35debf8f3deedf |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | MAP9 CLUAP1 MNS1 RSPH4A SYNE1 CNTRL DIAPH2 CC2D2A CCDC180 DNAH9 | 1.92e-09 | 198 | 154 | 10 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 2.02e-09 | 199 | 154 | 10 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.21e-08 | 190 | 154 | 9 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.02e-08 | 197 | 154 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.15e-08 | 198 | 154 | 9 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 3.29e-08 | 199 | 154 | 9 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 3.43e-08 | 200 | 154 | 9 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.43e-08 | 200 | 154 | 9 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-07 | 185 | 154 | 8 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.75e-07 | 185 | 154 | 8 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-07 | 187 | 154 | 8 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-07 | 191 | 154 | 8 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.26e-07 | 196 | 154 | 8 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.43e-07 | 197 | 154 | 8 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.43e-07 | 197 | 154 | 8 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.43e-07 | 197 | 154 | 8 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.43e-07 | 197 | 154 | 8 | 7c9df6025b9d168bd6d041c6cff1e87e08b11847 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.43e-07 | 197 | 154 | 8 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 4.60e-07 | 198 | 154 | 8 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 4.60e-07 | 198 | 154 | 8 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | CV-Mild-1|CV / Virus stimulation, Condition and Cluster | 4.60e-07 | 198 | 154 | 8 | 4b078714c49e7befb7b113d72485e712236d35fa | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.78e-07 | 199 | 154 | 8 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 4.78e-07 | 199 | 154 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 4.78e-07 | 199 | 154 | 8 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.96e-07 | 200 | 154 | 8 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.96e-07 | 200 | 154 | 8 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.96e-07 | 200 | 154 | 8 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 4.96e-07 | 200 | 154 | 8 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.96e-07 | 200 | 154 | 8 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.96e-07 | 200 | 154 | 8 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.96e-07 | 200 | 154 | 8 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.96e-07 | 200 | 154 | 8 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.96e-07 | 200 | 154 | 8 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.96e-07 | 200 | 154 | 8 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.96e-07 | 200 | 154 | 8 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.70e-06 | 164 | 154 | 7 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.25e-06 | 171 | 154 | 7 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.43e-06 | 173 | 154 | 7 | 5295ed31648abf8edff214cf67cd4769f20f9e6d | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.43e-06 | 173 | 154 | 7 | 36a471576a9d2325066bb14c2f2cd89c67b92915 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.62e-06 | 175 | 154 | 7 | a3f8c54c77bce9b035a4835945ab341909be4946 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.04e-06 | 179 | 154 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-06 | 182 | 154 | 7 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-06 | 183 | 154 | 7 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.52e-06 | 183 | 154 | 7 | 523896bd1a93bdda81a009768baa3a1bdbd108b8 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-06 | 183 | 154 | 7 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-06 | 184 | 154 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.78e-06 | 185 | 154 | 7 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.78e-06 | 185 | 154 | 7 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.92e-06 | 186 | 154 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.21e-06 | 188 | 154 | 7 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.21e-06 | 188 | 154 | 7 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.36e-06 | 189 | 154 | 7 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.51e-06 | 190 | 154 | 7 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-06 | 191 | 154 | 7 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.67e-06 | 191 | 154 | 7 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.67e-06 | 191 | 154 | 7 | 4a29b7d5cd10e9077699d3aa76e3db6c4d5a0cf6 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-06 | 191 | 154 | 7 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.83e-06 | 192 | 154 | 7 | 2cc712186e37fb21a964c032765c36a8b4a852cf | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.00e-06 | 193 | 154 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.17e-06 | 194 | 154 | 7 | 8985095f291c1b54e45f4edece49aa26e8c8b732 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 5.17e-06 | 194 | 154 | 7 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.17e-06 | 194 | 154 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | CV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster | 5.35e-06 | 195 | 154 | 7 | 2b8a72d7e755b9655c7a496000d10ff06e50862b | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.53e-06 | 196 | 154 | 7 | af00c31612e4fe068e5fccae05368edba46bbd20 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 5.53e-06 | 196 | 154 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 5.53e-06 | 196 | 154 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.72e-06 | 197 | 154 | 7 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.72e-06 | 197 | 154 | 7 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-06 | 197 | 154 | 7 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.72e-06 | 197 | 154 | 7 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.72e-06 | 197 | 154 | 7 | 927bf36bad3bcb7346c13b660777c1c0de7dc322 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 5.72e-06 | 197 | 154 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.72e-06 | 197 | 154 | 7 | 3e09158507df08c08e08613ce23617206280c911 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.72e-06 | 197 | 154 | 7 | d4dfb3b561d0783cdbee4e8d27009ad81df695cb | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.91e-06 | 198 | 154 | 7 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | COVID_vent-Lymphocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.91e-06 | 198 | 154 | 7 | ee80f647317377081b4bd194ee2801f556b3a53b | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.91e-06 | 198 | 154 | 7 | 34c564ece9a2b94dcf646e3c95b5be9c5ecfaafe | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type | 5.91e-06 | 198 | 154 | 7 | 9b161285df7a4e51618f3517cfc5b8221ba55786 | |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.91e-06 | 198 | 154 | 7 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| ToppCell | (11)_FOXN4+|World / shred by cell type by condition | 5.91e-06 | 198 | 154 | 7 | 516b1acdf997dd8debc3dca066519366e507b414 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.11e-06 | 199 | 154 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.11e-06 | 199 | 154 | 7 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.11e-06 | 199 | 154 | 7 | e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 6.11e-06 | 199 | 154 | 7 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.11e-06 | 199 | 154 | 7 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.11e-06 | 199 | 154 | 7 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.11e-06 | 199 | 154 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | COVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.11e-06 | 199 | 154 | 7 | 5f914962e2572b0c6372465b81b7496fa663d93c | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 6.31e-06 | 200 | 154 | 7 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 6.31e-06 | 200 | 154 | 7 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 6.31e-06 | 200 | 154 | 7 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.31e-06 | 200 | 154 | 7 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 6.31e-06 | 200 | 154 | 7 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.31e-06 | 200 | 154 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.31e-06 | 200 | 154 | 7 | 410b1a31de21c57d87ca2104f61cf4a7d4dd2f30 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.31e-06 | 200 | 154 | 7 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.31e-06 | 200 | 154 | 7 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 6.31e-06 | 200 | 154 | 7 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 6.31e-06 | 200 | 154 | 7 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.11e-05 | 49 | 101 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | B0683 | 1.21e-06 | 117 | 152 | 8 | CID006398969 | |
| Disease | unipolar depression, bipolar disorder | 1.58e-05 | 156 | 150 | 7 | EFO_0003761, MONDO_0004985 | |
| Disease | Malignant neoplasm of breast | PRRG1 TBC1D9B ANK2 SYNE1 SPTAN1 TRPC4 CD109 PPA1 ATF2 TYMS SYNE2 ITSN2 EIF2S2 MACF1 DMD DNAH9 GOLGB1 | 3.48e-05 | 1074 | 150 | 17 | C0006142 |
| Disease | Simpson-Golabi-Behmel syndrome | 7.68e-05 | 3 | 150 | 2 | cv:C4317043 | |
| Disease | autosomal dominant auditory neuropathy 1 (implicated_via_orthology) | 7.68e-05 | 3 | 150 | 2 | DOID:0060690 (implicated_via_orthology) | |
| Disease | response to tenofovir | 1.33e-04 | 51 | 150 | 4 | EFO_0009279 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 1.53e-04 | 4 | 150 | 2 | cv:CN293514 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 2.54e-04 | 5 | 150 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 2.54e-04 | 5 | 150 | 2 | C0410190 | |
| Disease | cholangiocarcinoma, sclerosing cholangitis | 2.54e-04 | 5 | 150 | 2 | EFO_0004268, EFO_0005221 | |
| Disease | urate measurement, bone density | MYL1 SYNE1 ADGRB3 TDO2 GBP5 DIAPH1 CTNNA1 PRKDC CPSF2 DNAH9 UTRN | 3.41e-04 | 619 | 150 | 11 | EFO_0003923, EFO_0004531 |
| Disease | Emery-Dreifuss muscular dystrophy | 3.80e-04 | 6 | 150 | 2 | cv:C0410189 | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 3.80e-04 | 6 | 150 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 3.80e-04 | 6 | 150 | 2 | C0410189 | |
| Disease | intellectual disability (is_implicated_in) | 4.73e-04 | 30 | 150 | 3 | DOID:1059 (is_implicated_in) | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 5.30e-04 | 7 | 150 | 2 | C0751337 | |
| Disease | Squamous cell carcinoma of lung | 5.73e-04 | 32 | 150 | 3 | C0149782 | |
| Disease | underweight body mass index status | 9.03e-04 | 9 | 150 | 2 | EFO_0005936 | |
| Disease | osteochondrodysplasia (implicated_via_orthology) | 9.03e-04 | 9 | 150 | 2 | DOID:2256 (implicated_via_orthology) | |
| Disease | influenza A (H1N1) | 1.03e-03 | 87 | 150 | 4 | EFO_1001488 | |
| Disease | Congenital Heart Defects | 1.46e-03 | 44 | 150 | 3 | C0018798 | |
| Disease | upper face morphology measurement | 1.54e-03 | 97 | 150 | 4 | EFO_0010949 | |
| Disease | mean corpuscular hemoglobin concentration | PPP1R21 SWAP70 SEPTIN4 MYLK2 TYMS UBAP2L NFE2L2 CC2D2A MACF1 PRKDC EIF4G3 TXN2 ARHGAP21 GOLGB1 | 1.57e-03 | 1105 | 150 | 14 | EFO_0004528 |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.64e-03 | 12 | 150 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Spina Bifida | 1.64e-03 | 12 | 150 | 2 | C0080178 | |
| Disease | Status Dysraphicus | 1.64e-03 | 12 | 150 | 2 | C0038219 | |
| Disease | Congenital myopathy (disorder) | 1.64e-03 | 12 | 150 | 2 | C0270960 | |
| Disease | Rachischisis | 1.64e-03 | 12 | 150 | 2 | C0266508 | |
| Disease | Gastrointestinal Stromal Sarcoma | 1.77e-03 | 47 | 150 | 3 | C3179349 | |
| Disease | Primary Ciliary Dyskinesia | 1.77e-03 | 47 | 150 | 3 | C4551720 | |
| Disease | male infertility (implicated_via_orthology) | 1.93e-03 | 13 | 150 | 2 | DOID:12336 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 2.11e-03 | 447 | 150 | 8 | C3714756 | |
| Disease | Gastrointestinal Stromal Tumors | 2.12e-03 | 50 | 150 | 3 | C0238198 | |
| Disease | colorectal cancer | 3.86e-03 | 604 | 150 | 9 | MONDO_0005575 | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 4.15e-03 | 19 | 150 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | unipolar depression, response to bupropion, mood disorder | 4.15e-03 | 19 | 150 | 2 | EFO_0003761, EFO_0004247, EFO_0006326 | |
| Disease | Familial aplasia of the vermis | 4.59e-03 | 20 | 150 | 2 | cv:C0431399 | |
| Disease | haptoglobin measurement | 5.06e-03 | 21 | 150 | 2 | EFO_0004640 | |
| Disease | muscular dystrophy (implicated_via_orthology) | 5.06e-03 | 21 | 150 | 2 | DOID:9884 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NKFAALDNEEEDKEE | 191 | Q8NE71 | |
| EDAKSQEQVFGLDKE | 961 | Q7Z7A1 | |
| LDDVDAAFDKIQQLK | 116 | Q9P2I0 | |
| LNEEQKEFQKVAFDF | 41 | Q9UKU7 | |
| EEDQKSFFEFLVLNK | 146 | O60242 | |
| LLSKKNDEFIEFNEV | 291 | Q9C0F1 | |
| ALIFKKEDVNFQDNE | 26 | O15084 | |
| TNEEKDLNSEDQKAF | 286 | Q8N302 | |
| PFENEFKKASEDDIK | 91 | P15336 | |
| KFKNEVNTLEEEFLA | 451 | Q8IYA2 | |
| KDFEDLFKQEESLKN | 2026 | P11532 | |
| LDQANDVINKFESKF | 1091 | Q9P1Z9 | |
| VKEDRFENNELFAKL | 801 | O60610 | |
| QLKVFDENKEDDLTE | 376 | O60879 | |
| AKAEEEFNKAQTVFE | 171 | Q9UBW5 | |
| FFFKDEQKAEDELAK | 1271 | Q5T5Y3 | |
| DQAEQLSKEQKEFFA | 1111 | Q9UHB7 | |
| ELNDDDKDDEIVFKQ | 251 | Q9BYG3 | |
| QKFNEHIKDDKGEDF | 236 | Q15032 | |
| SAKDNFNVDEIFLKL | 186 | Q6IQ22 | |
| NLNFDTTEEKLKEVF | 736 | Q9Y4C8 | |
| FKDTIEKINFENANL | 71 | Q9ULJ1 | |
| QQKTDEDTDFKEFLK | 1316 | Q9NZM3 | |
| QTELQDKSEFSDVDK | 801 | O75665 | |
| SDVDKLAFKDNEEFE | 811 | O75665 | |
| IDEQFDKEKANLEAF | 376 | P33176 | |
| DDKVDKTLEQQENFA | 1351 | Q01484 | |
| QQAEDSEEDKKFLTG | 421 | Q9NP74 | |
| KEADEDFFDILVKCQ | 591 | P81274 | |
| NDLEKQEFEKALETI | 196 | Q92619 | |
| VKSFSESQNKDEEFE | 126 | Q49MG5 | |
| QDLFNEDFEEKKEPE | 326 | Q96JK9 | |
| DVVEDFKNKYEDEIN | 171 | P08729 | |
| DEFFKELLENAEKSL | 106 | O75487 | |
| LTEENTEKELENFKA | 556 | Q9Y6F6 | |
| KKAAAEDVNVTFEDQ | 6 | Q9NQP4 | |
| QLFEFLEKEAAEKFI | 231 | A8MYZ0 | |
| EDEDEAGLQKSLKFN | 926 | Q08174 | |
| DEAKDFVSNLIVKDQ | 511 | Q9H1R3 | |
| QEKAFFAQLQLDEET | 66 | Q16236 | |
| IKVEAFDNEFEATQK | 336 | Q16649 | |
| ETERFFDELTKEKDQ | 961 | Q99550 | |
| EFQDISEEAKEFISK | 326 | Q86YV6 | |
| IEDDEKFFTTGQKEL | 71 | Q0VAA2 | |
| VEFETKEQAAKAIEF | 171 | Q4G0J3 | |
| SDEGELFLKKQEDFE | 281 | Q8N9T8 | |
| FKDVDQSFQKELETL | 371 | Q96PP8 | |
| EFSKEQQDEFKEAFL | 46 | P05976 | |
| NTVFKIFDVDKDDQL | 476 | Q86XE3 | |
| SVFDEDLQKKIEENE | 106 | Q6ZMI0 | |
| DVEFLPKEFQQDESK | 226 | Q5TGP6 | |
| ASDDLDDLNFFNQKK | 66 | P20042 | |
| ELDESFKEFGKNREV | 111 | O15265 | |
| DVKDKNSVFSVLDEE | 1206 | Q9UPN3 | |
| QDELQKFLQDHKEFE | 3881 | Q9UPN3 | |
| FKTEADAEKTFEEKQ | 436 | P19338 | |
| DNDEFNISFIKSNEE | 1621 | Q9UMZ3 | |
| DNLDKAFEKLQTAIE | 511 | Q9NZW5 | |
| KNFEDLQNEIKDSEI | 1166 | A1KZ92 | |
| FDLDVAVKENKDDLN | 1281 | Q6YHK3 | |
| EKDELNVKQEDAVFE | 191 | Q6JEL2 | |
| AKKDTEQEESVNEFL | 6 | P22612 | |
| EKFESQEDEKLLQAT | 1256 | Q9P2K1 | |
| QLIEDFLAKEEKNFA | 321 | Q8NA47 | |
| NFKQVEAELIDKLDS | 1131 | Q8IZD9 | |
| EQVASFQEEKSKLDA | 686 | P35221 | |
| KLKFDIETAQEDFEE | 106 | Q5T0U0 | |
| FTDNKEKLDDISNDE | 321 | P0C221 | |
| EKLDDISNDEKNEFL | 326 | P0C221 | |
| EKASDKETAQFQAEE | 171 | I3L3R5 | |
| EQVDVESIDFSKENK | 656 | Q96JM3 | |
| QKLAEFIDFLDKNDE | 331 | Q495W5 | |
| FSLSKDEDENNKFNE | 336 | Q8TF40 | |
| IIDDLQLFEKSFKNE | 456 | Q6ZRK6 | |
| KFKNEVNTLEEEFLA | 501 | Q3MJ40 | |
| QFGQFSKDKALEEEE | 1366 | Q9BTC0 | |
| DKVDKTLEQQENFEE | 1336 | Q12955 | |
| ELSEEQKQEIKDAFE | 21 | O15182 | |
| QKQEIKDAFELFDTD | 26 | O15182 | |
| EEQEEKEQFFARLEK | 126 | Q5TB80 | |
| LNVDEFEEIFKTKAQ | 656 | Q96PY5 | |
| FNAEFKDKDFAIDII | 206 | Q15181 | |
| EKKLQDDALAFEEFL | 151 | Q502W7 | |
| EEIKQVSEDDFSKLQ | 321 | Q8IYD9 | |
| IEGKELENFFQELEK | 36 | P22676 | |
| KEFEQIEQLKSDDSN | 296 | Q6PCB8 | |
| EEKDFDLFDKIQTEV | 2721 | Q9NYC9 | |
| KFKNEVNTLEEEFLA | 501 | A2RUR9 | |
| LEEKSENEAKCFFQV | 2421 | Q9C0D2 | |
| DNRKLFEAEEQDLFK | 266 | Q9H4M9 | |
| FDDNLKFKNIINEED | 131 | Q96T23 | |
| KEFEEASSKLEEFVN | 241 | Q5VT52 | |
| IDNFDELDIKFKSIV | 2856 | Q6ZTR5 | |
| CQKEFEKDKADDDVF | 841 | O43432 | |
| DPDENKENEAFEFKK | 136 | P30304 | |
| DKKQAQALAFEESEV | 56 | Q8TBY8 | |
| KELVLQAAKEEEENF | 361 | Q8NEH6 | |
| AKQKELRFDVFQEED | 171 | Q5TD94 | |
| EDFSFQEDSLKNIKD | 1901 | P46939 | |
| DDFLEFAKDKNFQVL | 571 | Q96JX3 | |
| ALDQFVNFSEQKEKL | 986 | Q9UQE7 | |
| DLEKNRINEFEKSFD | 1601 | Q8WUY3 | |
| ATLAEDKEKEEEFQQ | 456 | P35499 | |
| DEDEDFKLQDQALKE | 326 | O43236 | |
| KFEFAVKFNALELDD | 331 | Q03181 | |
| DAKSTVELFKFQEEE | 136 | P27169 | |
| DESFKDTAQEELKTQ | 2806 | Q8NF91 | |
| NENKTFDDSFKEKEI | 3106 | Q8WXH0 | |
| EFQKQKEVLLSLFDE | 256 | P48775 | |
| SEDIQDPVSDKFFKE | 971 | Q13393 | |
| KDEEFIRKFALFDEQ | 1201 | P21675 | |
| NEDDDASFKIKTVAQ | 216 | O60841 | |
| KIGFEEKDIAANEEN | 31 | O75368 | |
| EQESKKGFDQEEVFE | 816 | P30876 | |
| EFKNDLIDDKEFDIP | 46 | Q8N3P4 | |
| VLALTFEDFKNDKQA | 791 | Q8N3P4 | |
| AEFEKDFKEVFAIQE | 561 | Q9H930 | |
| LDENKDSLINFKEFV | 891 | Q66K14 | |
| AFIVASFENKDENKD | 111 | Q14201 | |
| KNEAKTKADFFEDEN | 541 | O95573 | |
| FNVEFDDSQDKAVLK | 66 | P00918 | |
| EDFFANKLDQEVQKD | 216 | Q96M20 | |
| QEALRKGDDVKFEEF | 226 | Q9NPF2 | |
| QEFQIFLENLKDDDA | 136 | A8MTZ7 | |
| FDEAAKVLKFNCEEN | 51 | Q96BR5 | |
| SEIVEEDVNKFKFDL | 116 | Q96AJ1 | |
| QLSDDEKFLFVDKNF | 6 | P35749 | |
| DKFVGIKDEDQLEAF | 146 | Q99757 | |
| KKVEAEFDEQADESN | 296 | O43298 | |
| FDKNDSDFEAKVKQL | 46 | Q5T6F2 | |
| IEKDIHDFEFQSQKD | 106 | Q96N58 | |
| NKDDQITLDEFKEAA | 161 | P62760 | |
| NDADFEEKVKQLIDI | 46 | Q14157 | |
| FNKDQLEEFKEAFEL | 61 | P14649 | |
| ESVEELKKQFNDEET | 111 | P56962 | |
| ADLEQVEVLQKKFDD | 1121 | Q13813 | |
| KFDVLDENQSKLSED | 336 | Q6Q0C0 | |
| EKIDDFKAEDFQIEG | 286 | P04818 | |
| DFTTKSEKFQEEEFQ | 176 | Q9BTF0 | |
| SEKFQEEEFQNDIEK | 181 | Q9BTF0 | |
| ALKQKFAFQEDDSFE | 316 | Q6P444 | |
| TDNDSQEIFKLAKDV | 2491 | P78527 | |
| EAREAFENNEKTKEF | 46 | O14668 | |
| DLEANFEKIENELKE | 96 | Q93050 | |
| DQDGVFKEFLEEIIK | 726 | Q7Z3V4 | |
| KEIFDELLETEKNSQ | 951 | Q86T82 | |
| IADTFQEQLEEKNFE | 496 | Q9UJ78 | |
| LEAEFEKNFKEVFAI | 846 | Q13342 | |
| FILEKVQDNFDKIEF | 76 | Q9UH65 | |
| KDNGAIEFTFDLEKE | 491 | Q9Y3S1 | |
| DEKLIEKENQIDTAF | 1181 | Q9BXT5 | |
| FVQVVKTDENKDFDD | 1676 | O15050 | |
| ELDNVFFKKENVEQC | 1436 | Q5T5U3 | |
| QLTEEQKNEFKAAFD | 11 | P63316 | |
| LETTEEDKQKNFLFL | 166 | Q7L0Y3 | |
| KDAEAVQKFFLEEIQ | 61 | Q15388 | |
| ELQELSKVENEFKSE | 226 | Q9UBN4 | |
| EQEKAELFTDKFCQV | 46 | Q5H9K5 | |
| EDNFVLESEKEKFVE | 791 | Q9BYP7 | |
| EEKLAAEEQFQALVK | 1081 | Q14789 | |
| ALDFSDDEKEKEAKQ | 311 | Q96HR8 | |
| DNLTKQLFDDVQKEE | 991 | Q9NQX4 |